post-sitemap2-xml.html

https://www.tempus.com/publications/genomic-and-transcriptomic-mediators-of-resistance-to-antibody-drug-conjugates-adcs-in-metastatic-breast-cancer-mbc-a-comprehensive-multi-center-study/ 2025-05-01T18:32:53+00:00 https://www.tempus.com/publications/stratification-of-cell-therapies-in-solid-tumor-organoids-using-deep-learning-derived-imaging-metrics/ 2025-05-01T18:34:12+00:00 https://www.tempus.com/publications/genetic-and-clinical-landscape-of-nutm1-structural-variants/ 2025-05-01T18:35:53+00:00 https://www.tempus.com/publications/investigating-the-clinical-landscape-and-biological-impact-of-sf3b1-hotspot-mutations-in-breast-cancer/ 2025-05-01T18:37:15+00:00 https://www.tempus.com/publications/identification-of-predictive-biomarkers-of-response-to-adcs-by-hts-of-highly-molecularly-characterized-panels-of-patient-derived-organoids-pdos/ 2025-05-01T18:40:24+00:00 https://www.tempus.com/publications/association-between-lag3-expression-and-immune-checkpoint-inhibitor-ici-efficacy-in-advanced-melanoma/ 2025-05-01T18:42:00+00:00 https://www.tempus.com/publications/visium-hd-combined-with-deep-learning-based-cell-segmentation-on-he-images-yield-accurate-cell-annotation-at-single-cell-resolution/ 2025-05-01T18:43:41+00:00 https://www.tempus.com/publications/functional-precision-medicine-uncovering-high-actionability-in-rare-cancers-beyond-genomics/ 2025-05-01T18:45:17+00:00 https://www.tempus.com/publications/metabolic-and-tumor-immune-cell-landscapes-are-significantly-different-amongst-kras-mutational-variants-in-non-small-cell-lung-cancer/ 2025-05-01T18:46:35+00:00 https://www.tempus.com/publications/comprehensive-whole-genome-sequencing-wgs-assay-provides-diagnostic-insight-into-clinically-relevant-genomic-alterations-across-myeloid-malignancies/ 2025-05-01T18:47:56+00:00 https://www.tempus.com/publications/enhancing-clonal-hematopoiesis-variant-detection-in-tumor-normal-matched-sequencing-using-machine-learning/ 2025-05-01T18:49:20+00:00 https://www.tempus.com/publications/benchmarking-of-germline-copy-number-variant-callers-from-whole-genome-sequencing-data-for-clinical-applications/ 2025-05-05T21:17:22+00:00 https://www.tempus.com/news/tempus-reports-first-quarter-2025-results/ 2025-05-06T20:05:56+00:00 https://www.tempus.com/wp-content/uploads/2025/05/2025-Q1_PR-0_v3.png https://www.tempus.com/wp-content/uploads/2025/05/2025-Q1_PR-1_v3.png https://www.tempus.com/wp-content/uploads/2025/05/2025-Q1_PR-2_v3.png https://www.tempus.com/wp-content/uploads/2025/05/2025-Q1_PR-3_v3.png https://www.tempus.com/wp-content/uploads/2025/05/2025-Q1_PR-4_v3.png https://www.tempus.com/wp-content/uploads/2025/05/2025-Q1_PR-5_v3.png https://www.tempus.com/wp-content/uploads/2025/05/2025-Q1_PR-6_v3.png https://www.tempus.com/wp-content/uploads/2025/05/2025-Q1_PR-7_v3.png https://www.tempus.com/wp-content/uploads/2025/05/2025-Q1_PR-8_v3.png https://www.tempus.com/wp-content/uploads/2025/05/2025-Q1_PR-9_v3.png https://www.tempus.com/wp-content/uploads/2025/05/2025-Q1_PR-10_v3.png https://www.tempus.com/publications/clsp-1025-a-first-in-class-precision-t-cell-engager-for-the-treatment-of-p53-mutant-cancers/ 2025-05-12T19:56:28+00:00 https://www.tempus.com/publications/enhancing-tcr-t-with-a-fas-based-switch-receptor-boosts-t-cell-engraftment-persistence-and-anti-tumor-activity-in-models-of-hard-to-treat-prame-solid-tumor-indications/ 2025-05-12T20:04:55+00:00 https://www.tempus.com/publications/analysis-of-multimodal-real-world-data-from-1248-breast-cancer-patients-reveals-distinct-novel-consensus-molecular-segments-associated-with-cdk4-6-inhibitor-resistance/ 2025-05-12T20:11:30+00:00 https://www.tempus.com/publications/real-world-experience-of-the-clinical-correlation-between-arid-gene-alterations-rna-expression-levels-and-treatment-benefit-of-immunotherapy-in-malignant-solid-tumors-2/ 2025-05-12T20:16:56+00:00 https://www.tempus.com/publications/baseline-biomarker-analyses-of-patients-with-chemorefractory-kras-g12c-mutated-metastatic-colorectal-cancer-mcrc-from-the-phase-3-codebreak-300-study/ 2025-05-12T20:20:55+00:00 https://www.tempus.com/publications/a-phase-i-open-label-multicentre-first-in-human-study-to-evaluate-safety-pharmacokinetics-and-efficacy-of-amg-404-a-pd-1-inhibitor-in-patients-with-advanced-solid-tumours/ 2025-05-12T21:15:29+00:00 https://www.tempus.com/news/tempus-enters-multi-year-strategic-collaboration-with-boehringer-ingelheim-to-advance-its-cancer-pipeline/ 2025-05-14T12:30:06+00:00 https://www.tempus.com/news/pr/tempus-announces-six-posters-accepted-for-presentation-at-ispor-2025/ 2025-05-13T20:05:01+00:00 https://www.tempus.com/publications/assessing-the-completeness-of-oncology-treatment-data-from-administrative-claims-a-benchmarking-study-against-abstracted-ehrs-using-patient-level-linkages/ 2025-05-16T18:27:09+00:00 https://www.tempus.com/publications/impact-of-ngs-testing-timing-on-real-world-treatment-patterns-and-clinical-outcomes-in-colorectal-cancer-a-retrospective-observational-study/ 2025-05-16T18:29:02+00:00 https://www.tempus.com/publications/impact-of-adverse-event-definitions-on-real-world-detection-of-oncology-immune-related-adverse-events/ 2025-05-16T18:29:40+00:00 https://www.tempus.com/publications/integrating-next-generation-sequencing-ehr-and-claims-data-to-extend-follow-up-in-a-real-world-advanced-lung-adenocarcinoma-biomarker-treatment-landscape/ 2025-05-16T18:30:54+00:00 https://www.tempus.com/publications/comparison-of-demographics-and-clinical-characteristics-using-real-world-data-from-tempus-multimodal-database-and-seer-cancer-registry-across-17-solid-cancer-cohorts/ 2025-05-16T18:32:40+00:00 https://www.tempus.com/publications/oncology-trial-emulation-using-real-world-electronic-health-record-data-results-of-the-coalition-to-advance-real-world-evidence-through-randomized-controlled-trial-emulation-care-initiative/ 2025-05-16T18:49:19+00:00 https://www.tempus.com/resources/content/articles/qa-advancing-early-detection-in-lung-cancer-the-role-of-incidental-pulmonary-nodules/ 2025-05-16T19:46:35+00:00 https://www.tempus.com/wp-content/uploads/2025/04/QA_-Advancing-early-detection-in-lung-cancer_-The-role-of-incidental-pulmonary-nodules.png https://www.tempus.com/wp-content/uploads/2023/04/KRAS-Expression_KRAS-Mutation-Status.png https://www.tempus.com/publications/structured-evaluation-of-oncology-real-world-data-quality-for-practical-applications/ 2025-05-16T21:26:44+00:00 https://www.tempus.com/publications/molecular-landscape-of-patients-pts-with-metastatic-breast-cancer-mbc-who-progressed-on-second-line-2l-selective-estrogen-receptor-degraders-serds/ 2025-05-19T14:51:19+00:00 https://www.tempus.com/news/tempus-announces-a-collaboration-with-verastem-to-develop-cdx-for-first-ever-fda-approved-kras-mutant-recurrent-low-grade-serous-ovarian-cancer-combination-treatment/ 2025-05-20T14:35:37+00:00 https://www.tempus.com/news/pr/tempus-to-present-at-the-william-blair-45th-annual-growth-stock-conference/ 2025-05-21T12:30:21+00:00 https://www.tempus.com/publications/assessing-the-reliability-accuracy-and-utility-of-clinical-abstraction-methods-from-unstructured-electronic-health-records-ehrs/ 2025-05-22T21:10:43+00:00 https://www.tempus.com/publications/clinical-utility-and-cost-effectiveness-of-a-molecular-biomarker-for-immune-checkpoint-inhibitor-response-monitoring-and-treatment-decisions/ 2025-05-22T21:10:19+00:00 https://www.tempus.com/publications/real-world-evaluation-of-the-reduction-in-complexity-of-ordering-dna-sequencing-tests-through-the-adoption-of-fast-healthcare-interoperability-resources-fhir-standards/ 2025-05-22T21:10:45+00:00 https://www.tempus.com/publications/a-natural-language-processing-nlp-approach-for-optical-character-recognition-ocr-resilient-extraction-correction-and-structuring-of-karyotype-data-in-oncology-clinical-notes/ 2025-05-22T21:10:50+00:00 https://www.tempus.com/publications/cohort-builder-in-tempus-lens-querying-a-large-oncology-database-with-generative-ai/ 2025-05-22T21:10:34+00:00 https://www.tempus.com/publications/esr1-mutations-and-associated-alterations-in-patients-with-estrogen-receptor-er-her2-positive-her2-breast-cancers-at-diagnosis-of-metastatic-disease-mbc/ 2025-05-22T21:10:16+00:00 https://www.tempus.com/publications/outcomes-for-patients-with-spop-mutated-castration-resistant-prostate-cancer-crpc-treated-with-an-androgen-receptor-pathway-inhibitor-arpi/ 2025-05-22T22:02:43+00:00 https://www.tempus.com/publications/prediction-of-sotorasib-response-duration-and-identification-of-clinically-actionable-resistance-mechanisms-using-an-rna-and-machine-learning-based-patient-classifier/ 2025-05-22T22:06:17+00:00 https://www.tempus.com/publications/exceptional-response-in-a-patient-with-mrcc-through-precision-guided-treatment-involving-immunotherapy-rechallenge-with-temsirolimus-and-bevacizumab/ 2025-05-23T21:34:14+00:00 https://www.tempus.com/news/a-decade-of-discovery-tempus-supported-almost-1500-research-projects-in-10-years/ 2025-05-28T12:30:50+00:00 https://www.tempus.com/resources/content/articles/qa-integrating-mrd-and-io-monitoring-with-the-tempus-portfolio-an-oncologists-perspective/ 2025-05-28T21:13:00+00:00 https://www.tempus.com/wp-content/uploads/2025/05/QA_-Integrating-MRD-and-IO-Monitoring-with-the-Tempus-portfolio_-An-oncologists-perspective.png https://www.tempus.com/news/tempus-announces-10-abstracts-accepted-for-presentation-at-the-2025-american-society-of-clinical-oncology-annual-meeting/ 2025-05-30T12:30:18+00:00 https://www.tempus.com/news/tempus-introduces-fuses-a-program-designed-to-transform-therapeutic-research-and-build-the-largest-diagnostic-platform-using-its-novel-foundation-model/ 2025-05-31T12:30:06+00:00 https://www.tempus.com/news/tempus-introduces-xm-an-assay-to-monitor-immunotherapy-response-for-patients-with-advanced-cancers/ 2025-06-02T12:30:03+00:00 https://www.tempus.com/publications/trop-2-expression-and-its-prognostic-impact-on-endometrial-cancer-a-real-world-data-analysis/ 2025-05-30T18:41:32+00:00 https://www.tempus.com/publications/basecamp-1-an-approach-to-improve-patient-screening-efficiency-and-to-provide-large-datasets-for-precision-medicine-clinical-trials/ 2025-05-30T18:45:23+00:00 https://www.tempus.com/publications/genomic-landscape-and-clinical-characteristics-of-patients-pts-with-neuroendocrine-prostate-cancer-nepc-with-or-without-aggressive-variant-prostate-cancer-characterized-by-molecular-signature-avp/ 2025-05-30T18:48:59+00:00 https://www.tempus.com/news/introducing-tempus-one-in-the-ehr-with-integrated-guidelines/ 2025-06-01T12:30:49+00:00 https://www.tempus.com/publications/investigation-of-liver-specific-gene-expression-signatures-in-prostate-cancers-prior-to-liver-metastases/ 2025-06-02T20:30:08+00:00 https://www.tempus.com/publications/real-world-utilization-of-comprehensive-genomic-profiling-cgp-in-head-and-neck-squamous-cell-carcinoma-scchn/ 2025-06-02T20:47:35+00:00 https://www.tempus.com/publications/clinical-implications-of-her3-overexpression-in-a-diverse-patient-cohort-with-prostate-cancer/ 2025-06-02T21:41:12+00:00 https://www.tempus.com/publications/enhancing-team-efficiency-for-genetic-risk-assessment-medical-oncology-led-germline-testing-for-pancreatic-cancer/ 2025-06-02T21:44:20+00:00 https://www.tempus.com/publications/outcomes-following-first-line-immune-checkpoint-inhibitors-with-or-without-chemotherapy-stratified-by-kras-mutational-status-a-real-world-analysis-in-patients-with-advanced-nsclc/ 2025-06-02T21:55:22+00:00 https://www.tempus.com/publications/lipid-metabolic-gene-expression-is-associated-with-decreased-overall-survival-and-immunogenicity-in-kras-stk11-nsclc/ 2025-06-03T17:21:00+00:00 https://www.tempus.com/publications/gemini-nsclc-study-integrated-longitudinal-multi-omic-biomarker-profiling-study-of-non-small-cell-lung-cancer-nsclc-patients/ 2025-06-03T17:29:08+00:00 https://www.tempus.com/publications/a-technology-enabled-clinical-trial-programs-impact-on-patient-screening-and-trial-enrollment-in-2024/ 2025-06-03T17:39:44+00:00 https://www.tempus.com/publications/immunodriver-1-driver-alterations-dalts-and-their-immunological-implications-in-early-and-metastatic-non-small-cell-lung-cancer-nsclc/ 2025-06-03T18:29:15+00:00 https://www.tempus.com/publications/concordance-between-human-epidermal-growth-factor-receptor-2-her2-status-by-immunohistochemistry-ihc-and-next-generation-sequencing-ngs-in-tissue-and-blood-samples-from-gastric-and-gastroesophag/ 2025-06-04T16:41:20+00:00 https://www.tempus.com/publications/transcriptomic-biomarkers-of-therapeutic-response-to-antibody-drug-conjugates-in-metastatic-breast-cancer-a-comprehensive-multi-center-study/ 2025-06-05T16:10:07+00:00 https://www.tempus.com/publications/real-world-analyses-to-evaluate-the-role-of-tigit-as-a-target-in-first-line-1l-gastric-gastroesophageal-junction-and-esophageal-adenocarcinomas-gc-gejc-eac/ 2025-06-05T17:25:38+00:00 https://www.tempus.com/publications/a-canadian-cancer-trials-group-liquid-biopsy-informed-platform-trial-to-evaluate-treatment-in-cdk4-6-inhibitor-resistant-er-her2-metastatic-breast/ 2025-06-05T17:26:44+00:00 https://www.tempus.com/publications/development-and-validation-of-the-immune-profile-score-ips-a-novel-multiomic-algorithmic-assay-for-stratifying-outcomes-in-a-real-world-cohort-of-patients-with-advanced-solid-cancer-treated-with-im/ 2025-06-06T19:28:24+00:00 https://www.tempus.com/publications/detection-of-kmt2a-partial-tandem-duplication-ptd-in-aml-by-whole-genome-sequencing-wgs-addressing-limitations-of-traditional-techniques-in-the-era-of-revumenib-approval/ 2025-06-06T19:43:28+00:00 https://www.tempus.com/news/pr/tempus-announces-collaboration-with-northwestern-universitys-abrams-research-center-on-neurogenomics-to-leverage-ai-for-alzheimers-disease-research/ 2025-06-12T12:30:35+00:00 https://www.tempus.com/resources/content/white-papers/accelerating-adc-development-with-tempus-ai/ 2025-06-11T20:00:18+00:00 https://www.tempus.com/wp-content/uploads/2024/05/Case-Study_ADC-White-Paper.jpg https://www.tempus.com/news/tempus-to-participate-in-td-cowens-4th-annual-tools-dx-revolution-conference/ 2025-06-17T12:30:35+00:00 https://www.tempus.com/resources/content/case-studies/harnessing-ai-and-time-to-increase-clinical-trial-enrollment/ 2025-06-17T16:52:40+00:00 https://www.tempus.com/wp-content/uploads/2024/10/Case-Study_Cleveland-Clinic.jpg https://www.tempus.com/resources/content/case-studies/development-of-a-clinical-algorithm-to-prognosticate-response-to-immunotherapy/ 2025-06-17T17:55:14+00:00 https://www.tempus.com/wp-content/uploads/2025/04/Case-Study_Development-of-a-clinical-algorithm.jpg https://www.tempus.com/resources/content/case-studies/sequencing-for-development-and-commercialization/ 2025-06-17T17:55:35+00:00 https://www.tempus.com/wp-content/uploads/2022/07/Tempus-case-study_Seq.png https://www.tempus.com/resources/content/webinars/ai-ml-in-action-demonstrating-real-world-impact-in-trial-design-patient-care/ 2025-06-20T20:24:38+00:00 https://www.tempus.com/wp-content/uploads/2023/05/Tempus-webinar_nP-PGx.jpg https://www.tempus.com/publications/defining-non-small-cell-lung-cancer-tumor-microenvironment-changes-at-primary-and-acquired-immune-checkpoint-inhibitor-resistance-using-clinical-and-real-world-data/ 2025-06-23T17:58:51+00:00 https://www.tempus.com/news/tempus-ai-inc-announces-proposed-convertible-senior-notes-offering-to-optimize-capital-structure-and-reduce-interest-expense/ 2025-06-30T15:17:38+00:00 https://www.tempus.com/news/tempus-announces-pricing-of-upsized-offering-of-650-million-of-convertible-senior-notes/ 2025-07-01T02:17:03+00:00 https://www.tempus.com/publications/blood-ctdna-vs-tumor-tissue-screening-for-the-detection-of-kras-mutations-in-low-grade-serous-ovarian-cancer/ 2025-07-01T16:28:29+00:00 https://www.tempus.com/publications/defining-non-small-cell-lung-cancer-tumor-microenvironment-changes-at-primary-and-acquired-immune-checkpoint-inhibitor-resistance-using-clinical-and-real-world-data-2/ 2025-07-01T16:37:36+00:00 https://www.tempus.com/publications/a-self-supervised-framework-for-laboratory-data-imputation-in-electronic-health-records/ 2025-07-01T17:27:45+00:00 https://www.tempus.com/publications/ai-driven-predictive-biomarker-discovery-with-contrastive-learning-to-improve-clinical-trial-outcomes/ 2025-07-01T17:34:20+00:00 https://www.tempus.com/publications/genomic-landscapes-of-early-onset-versus-average-onset-colorectal-cancer-populations-2/ 2025-07-01T17:47:01+00:00 https://www.tempus.com/publications/upregulation-of-pole-and-proficient-dna-repair-are-features-of-cicdux4-sarcomas/ 2025-07-01T17:51:21+00:00 https://www.tempus.com/publications/a-probabilistic-approach-for-building-disease-phenotypes-across-electronic-health-records/ 2025-07-01T17:55:39+00:00 https://www.tempus.com/publications/multiomic-characterization-of-early-and-metastatic-biliary-tract-cancer-btc/ 2025-07-07T21:19:29+00:00 https://www.tempus.com/publications/circulating-tumor-dna-ctdna-dynamics-predict-clinical-recurrence-in-liver-limited-metastatic-colorectal-cancer-mcrc-patients-resected-after-first-line-systemic-treatment/ 2025-07-07T21:20:42+00:00 https://www.tempus.com/publications/transcriptomic-analysis-of-homologous-recombination-repair-hrr-genes-in-brca1-2-and-palb2-wild-type-wt-metastatic-pancreatic-cancer-mpc-suggests-potential-platinum-sensitivity/ 2025-07-07T21:21:39+00:00 https://www.tempus.com/publications/genetic-and-oncogenic-features-of-rasgrf-fusions/ 2025-07-07T21:32:58+00:00 https://www.tempus.com/publications/real-world-adherence-patterns-of-comprehensive-genomic-profiling-to-biomarker-recommended-therapies-in-patients-with-advanced-non-small-cell-lung-cancer/ 2025-07-07T21:40:29+00:00 https://www.tempus.com/publications/a-molecular-biomarker-for-early-and-longitudinal-treatment-response-monitoring-in-a-real-world-cohort-of-advanced-solid-tumors-treated-with-targeted-therapies/ 2025-07-08T17:34:02+00:00 https://www.tempus.com/news/pr/tempus-expands-ai-enabled-care-pathway-intelligence-platform-into-breast-cancer/ 2025-07-11T18:25:34+00:00 https://www.tempus.com/news/pr/tempus-receives-u-s-fda-510k-clearance-for-tempus-ecg-low-ef-software/ 2025-07-16T12:04:04+00:00 https://www.tempus.com/publications/minimum-technical-preanalytical-patient-and-clinical-context-data-elements-for-cerebrospinal-fluid-liquid-biopsy-recommendations-for-public-database-submissions/ 2025-07-17T20:20:37+00:00 https://www.tempus.com/publications/germline-dna-repair-gene-mutations-and-clonal-hematopoiesis-ch-in-24849-patients-with-brca-associated-cancers/ 2025-07-17T20:27:32+00:00 https://www.tempus.com/publications/genomic-profiling-reveals-molecular-heterogeneity-in-patients-with-richter-transformation-rt-and-chronic-lymphocytic-leukemia-cll/ 2025-07-17T20:35:42+00:00 https://www.tempus.com/news/pr/tempus-to-report-second-quarter-2025-financial-results-on-august-8/ 2025-07-22T14:29:41+00:00 https://www.tempus.com/publications/evaluation-of-large-language-model-llm-based-clinical-abstraction-of-electronic-health-records-ehrs-for-non-small-cell-lung-cancer-nsclc-patients/ 2025-07-23T19:35:53+00:00 https://www.tempus.com/resources/content/videos/transforming-rd-with-generative-ai-and-real-world-data/ 2025-07-31T18:57:50+00:00 https://www.tempus.com/news/tempus-reports-second-quarter-2025-results/ 2025-08-08T10:00:25+00:00 https://www.tempus.com/wp-content/uploads/2025/08/2025-Q2_PR-0_v2.png https://www.tempus.com/wp-content/uploads/2025/08/2025-Q2_PR-1_v1-1.png https://www.tempus.com/wp-content/uploads/2025/08/2025-Q2_PR-2_v2-1.png https://www.tempus.com/wp-content/uploads/2025/08/2025-Q2_PR-3_v1.png https://www.tempus.com/wp-content/uploads/2025/08/2025-Q2_PR-4_v1.png https://www.tempus.com/wp-content/uploads/2025/08/2025-Q2_PR-5_v1.png https://www.tempus.com/wp-content/uploads/2025/08/2025-Q2_PR-6_v1-1.png https://www.tempus.com/wp-content/uploads/2025/08/2025-Q2_PR-7_v2-1.png https://www.tempus.com/wp-content/uploads/2025/08/2025-Q2_PR-8_v2-2.png https://www.tempus.com/wp-content/uploads/2025/08/2025-Q2_PR-9_v1.png https://www.tempus.com/wp-content/uploads/2025/08/2025-Q2_PR-10_v2.png https://www.tempus.com/publications/comprehensive-comparison-of-somatic-germline-and-immune-cell-profiles-in-upper-tract-and-bladder-urothelial-carcinoma/ 2025-08-11T15:20:39+00:00 https://www.tempus.com/publications/circulating-tumor-dna-ctdna-dynamics-in-liver-limited-metastatic-colorectal-cancer-mcrc-patients-resected-after-fi-rst-linesystemic-treatment/ 2025-08-13T16:58:56+00:00 https://www.tempus.com/publications/treatment-outcomes-and-resource-utilization-among-patients-with-metastatic-breast-and-advanced-epithelial-ovarian-cancer-by-brca1-2-and-hrd-status/ 2025-08-13T21:21:44+00:00 https://www.tempus.com/publications/milademetan-in-advanced-solid-tumors-with-mdm2-amplification-and-wild-type-tp53-pre-clinical-and-phase-2-clinical-trial-results/ 2025-08-13T21:27:56+00:00 https://www.tempus.com/publications/differential-gene-expression-and-pathway-analysis-of-invasive-mucinous-adenocarcinoma/ 2025-08-13T21:57:59+00:00 https://www.tempus.com/wp-content/uploads/2025/08/TABLE.jpg https://www.tempus.com/wp-content/uploads/2025/08/FIG.jpg https://www.tempus.com/resources/content/case-studies/revolutionizing-drug-screening-with-tempus-ais-advanced-imaging-capabilities/ 2025-08-15T20:36:20+00:00 https://www.tempus.com/wp-content/uploads/2024/10/Case-Study_LS_AI-and-Drug-Screening.jpg https://www.tempus.com/publications/molecular-characterization-of-patients-with-metastatic-invasive-lobular-carcinoma-ilc-using-real-world-data-to-describe-this-unique-clinical-entity/ 2025-08-18T17:46:36+00:00 https://www.tempus.com/publications/cd34-positive-acral-chondromyxoid-mesenchymal-neoplasm-harboring-a-novel-tcf4erg-fusion/ 2025-08-18T18:07:53+00:00 https://www.tempus.com/publications/olaparib-pembrolizumab-and-carboplatin-as-first-line-treatment-of-recurrent-or-metastatic-head-and-neck-squamous-cell-carcinoma-a-phase-ii-trial/ 2025-08-18T18:13:27+00:00 https://www.tempus.com/publications/mutational-analysis-of-primary-and-advanced-chordoma-tissue-using-next-generation-sequencing/ 2025-08-18T18:17:33+00:00 https://www.tempus.com/publications/proteomic-evaluation-of-her-2-expression-and-activation-in-tumors-that-are-rna-overexpressed-but-not-dna-amplified/ 2025-08-18T19:30:01+00:00 https://www.tempus.com/wp-content/uploads/2025/08/Screenshot-2025-08-18-at-2.26.18-PM.png https://www.tempus.com/news/tempus-announces-the-acquisition-of-paige/ 2025-08-22T13:24:39+00:00 https://www.tempus.com/publications/ai-driven-multimodal-algorithm-predicts-immunotherapy-and-targeted-therapy-outcomes-in-clear-cell-renal-cell-carcinoma/ 2025-08-25T15:32:40+00:00 https://www.tempus.com/resources/content/articles/qa-navigating-the-evolving-landscape-of-breast-cancer-care-using-ai/ 2025-08-28T18:59:14+00:00 https://www.tempus.com/wp-content/uploads/2025/05/QA_-Harnessing-generative-AI-to-refine-clinical-research-drug-development.png https://www.tempus.com/publications/multimodal-ai-correlates-of-glucose-spikes-in-people-with-normal-glucose-regulation-pre-diabetes-and-type-2-diabetes/ 2025-09-02T15:40:11+00:00 https://www.tempus.com/publications/case-of-relapsed-metastatic-cutaneous-squamous-cell-carcinoma-with-her2-mutation-treated-with-trastuzumab/ 2025-09-02T15:43:26+00:00 https://www.tempus.com/news/pr/tempus-to-participate-in-morgan-stanleys-23nd-annual-global-healthcare-conference/ 2025-09-03T20:20:58+00:00 https://www.tempus.com/news/northwestern-medicine-becomes-first-health-system-to-integrate-tempus-generative-ai-co-pilot-david-into-its-ehr-platform/ 2025-09-04T12:30:23+00:00 https://www.tempus.com/publications/real-world-validation-of-the-purity-independent-subtyping-of-tumors-classifier-for-informing-therapy-selection-in-pancreatic-ductal-adenocarcinoma/ 2025-09-05T15:12:34+00:00 https://www.tempus.com/publications/validation-of-a-composite-mortality-endpoint-in-a-large-clinico-genomic-real-world-database-of-patients-with-advanced-cancer/ 2025-09-05T15:17:23+00:00 https://www.tempus.com/publications/clinical-echocardiographic-and-socioeconomic-predictors-of-progression-and-outcomes-in-patients-with-moderate-aortic-stenosis/ 2025-09-05T15:25:40+00:00 https://www.tempus.com/publications/lower-checkpoint-gene-expression-is-associated-with-primary-resistance-to-nivolumab-ipilimumab-combination-in-advanced-renal-cell-carcinoma/ 2025-09-05T15:41:55+00:00 https://www.tempus.com/wp-content/uploads/2025/07/Screenshot-2025-09-05-at-10.40.55-AM.png https://www.tempus.com/publications/what-is-the-place-for-digital-health-and-artificial-intelligence-in-pediatric-primary-care-a-call-to-action-from-the-european-confederation-of-primary-care-paediatricians-ecpcp/ 2025-09-08T17:46:02+00:00 https://www.tempus.com/publications/the-efficacy-and-use-of-artificial-intelligence-in-medical-data-management-and-decision-making-to-future-horizons/ 2025-09-08T17:49:38+00:00 https://www.tempus.com/publications/next-generation-sequencing-of-intraoperatively-acquired-cerebrospinal-fluid-and-matched-tumor-tissue-in-patients-undergoing-surgical-resection-for-glioblastoma/ 2025-09-08T17:53:36+00:00 https://www.tempus.com/news/tempus-announces-new-study-in-jco-precision-oncology-validating-purist-algorithm-for-enhanced-therapy-selection-in-pancreatic-cancer/ 2025-09-09T12:30:13+00:00 https://www.tempus.com/uncategorized/tempus-receives-u-s-fda-special-510k-clearance-for-updated-tempus-pixel-device/ 2025-09-11T12:30:27+00:00 https://www.tempus.com/publications/biomarkers-of-immunotherapy-response-in-neuro-oncology/ 2025-09-15T16:19:22+00:00 https://www.tempus.com/publications/clinical-morphologic-and-molecular-findings-in-ntrk3-fusion-spitz-neoplasms/ 2025-09-15T16:32:57+00:00 https://www.tempus.com/publications/circulating-tumor-dna-and-tissue-testing-for-pancreatobiliary-tumors/ 2025-09-15T16:46:12+00:00 https://www.tempus.com/resources/content/webinars/navigating-new-frontiers-in-breast-cancer-care-gap-closure-the-role-of-providers-and-ai/ 2025-09-15T17:10:05+00:00 https://www.tempus.com/wp-content/uploads/2025/07/Mercy-Health-1.png https://www.tempus.com/resources/content/articles/qa-navigating-new-frontiers-in-breast-cancer-care-with-ai/ 2025-09-15T17:24:33+00:00 https://www.tempus.com/wp-content/uploads/2025/05/QA_-Harnessing-generative-AI-to-refine-clinical-research-drug-development.png https://www.tempus.com/resources/content/articles/from-fragmentation-to-integration-how-ai-powered-site-networks-are-powering-clinical-research/ 2025-09-15T17:24:38+00:00 https://www.tempus.com/wp-content/uploads/2025/08/From-fragmentation-to-integration_-How-AI-powered-site-networks-are-powering-clinical-research.jpg https://www.tempus.com/resources/content/webinars/closing-care-gaps-with-ai-the-next-competitive-edge-in-pharma/ 2025-09-15T17:25:47+00:00 https://www.tempus.com/wp-content/uploads/2025/07/Menarini-Stemline.png https://www.tempus.com/resources/content/white-papers/minimal-residual-disease-mrd-testing-a-practical-guide-for-clinicians/ 2025-09-16T16:31:40+00:00 https://www.tempus.com/wp-content/uploads/2025/09/White-Paper_MRD-guide.jpg https://www.tempus.com/news/tempus-receives-u-s-fda-510k-clearance-for-tempus-xr-ivd-its-rna-ngs-in-vitro-diagnostic-device/ 2025-09-22T12:30:53+00:00 https://www.tempus.com/publications/clinicogenomic-landscape-and-outcomes-of-metastatic-colorectal-cancer-patients-with-pathogenic-gnas-variants/ 2025-09-26T12:13:11+00:00 https://www.tempus.com/resources/content/white-papers/precision-medicine-2-0-the-operating-system-for-oncology-rd/ 2025-09-26T17:55:45+00:00 https://www.tempus.com/wp-content/uploads/2025/08/White-Paper_Precision-Medicine-2.0_16.9.jpg https://www.tempus.com/publications/mid-treatment-ctdna-to-predict-outcomes-in-stage-iib-iiic-nsclc-treated-with-mri-adapted-chemoradiation-2/ 2025-09-29T17:53:58+00:00 https://www.tempus.com/publications/validation-and-clinical-utility-of-a-pan-cancer-circulating-tumor-dna-assay-as-a-first-approach-test/ 2025-09-29T18:01:00+00:00 https://www.tempus.com/publications/timing-of-molecular-pet-imaging-after-salvage-radiation-therapy-for-recurrent-oligometastatic-castration-sensitive-prostate-cancer/ 2025-09-29T19:17:00+00:00 https://www.tempus.com/publications/clinical-impact-of-next-generation-sequencing-guided-targeted-therapies-in-advanced-cancer-a-systematic-review-and-meta-analysis/ 2025-09-29T19:28:25+00:00 https://www.tempus.com/publications/exploratory-evaluation-of-the-somatic-and-immunologic-landscape-of-primary-and-metastatic-cervical-cancer-to-better-inform-future-clinical-trial-development/ 2025-10-02T15:56:57+00:00 https://www.tempus.com/news/tempus-selected-by-arpa-h-to-provide-cro-and-testing-services-for-the-adapt-program-advancing-precision-cancer-therapy/ 2025-10-09T12:30:47+00:00 https://www.tempus.com/publications/mondo-integrating-disease-terminology-across-communities/ 2025-10-10T15:04:33+00:00 https://www.tempus.com/resources/content/articles/serena-6-qa-an-authors-insights-on-clinical-integration-and-future-directions/ 2025-10-10T19:02:10+00:00 https://www.tempus.com/wp-content/uploads/2025/10/SERENA-6-QA_-An-Authors-Insights-on-Clinical-Integration-and-Future-Directions.jpg https://www.tempus.com/publications/distinct-and-convergent-effects-of-sf3b1-mutations-in-human-breast-cancer/ 2025-10-13T15:08:16+00:00 https://www.tempus.com/publications/lower-checkpoint-gene-expression-is-associated-with-primary-resistance-to-nivolumab-ipilimumab-combination-in-advanced-renal-cell-carcinoma-2/ 2025-10-13T15:33:47+00:00 https://www.tempus.com/wp-content/uploads/2025/10/TABLE.jpeg https://www.tempus.com/publications/clinicopathologic-and-molecular-genetic-features-of-spindle-cell-rhabdomyosarcoma-harboring-zfp64ncoa2-3-fusions-a-series-of-14-cases/ 2025-10-13T15:44:20+00:00 https://www.tempus.com/news/pr/tempus-announces-six-abstracts-accepted-for-presentation-at-the-european-society-for-medical-oncology-congress-2025/ 2025-10-15T13:24:26+00:00 https://www.tempus.com/news/pr/tempus-announces-collaboration-with-whitehawk-therapeutics-to-advance-biomarker-driven-oncology-research/ 2025-10-16T13:55:19+00:00 https://www.tempus.com/news/pr/tempus-to-report-third-quarter-2025-financial-results-on-november-4/ 2025-10-21T12:30:44+00:00 https://www.tempus.com/publications/analysis-of-cfdna-fragmentomics-metrics-and-commercial-targeted-sequencing-panels/ 2025-10-23T20:50:14+00:00 https://www.tempus.com/publications/a-quantitative-bayesian-informed-approach-to-gene-specific-variant-classification-updated-expert-panel-recommendations-improve-classification-of-tp53-germline-variants-for-li-fraumeni-syndrome/ 2025-10-24T16:34:20+00:00 https://www.tempus.com/publications/precision-oncology-for-high-grade-gliomas-a-tumor-organoid-model-for-adjuvant-treatment-selection/ 2025-10-24T16:39:26+00:00 https://www.tempus.com/publications/high-grade-angiosarcoma-transformation-in-schwannoma-and-smarcb1-mutation-a-case-report/ 2025-10-24T16:45:04+00:00 https://www.tempus.com/publications/a-quantitative-bayesian-informed-approach-to-gene-specific-variant-classification-updated-expert-panel-recommendations-improve-classification-of-tp53-germline-variants-for-li-fraumeni-syndrome-2/ 2025-10-27T14:56:35+00:00 https://www.tempus.com/publications/real-world-characterization-of-ptk7-an-oncofetal-pseudokinase-expressed-in-multiple-solid-tumors/ 2025-10-27T17:58:17+00:00 https://www.tempus.com/publications/gdf15-mrna-expression-in-biliary-tract-cancer-btc-a-multiomic-analysis-of-its-prognostic-relevance-and-association-with-tumor-immune-states-in-a-large-real-world-cohort/ 2025-10-27T18:02:15+00:00 https://www.tempus.com/publications/pin1-mrna-expression-in-biliary-tract-cancer-a-multiomic-analysis-of-its-prognostic-relevance-and-association-with-tumor-immune-states-in-a-large-real-world-cohort/ 2025-10-27T18:02:52+00:00 https://www.tempus.com/publications/machine-learning-enabled-assessment-of-risk-for-drug-induced-qt-prolongation-at-the-time-of-prescribing/ 2025-10-27T18:23:18+00:00 https://www.tempus.com/publications/circulating-tumor-dna-tumor-fraction-as-a-precision-biomarker-for-radiotherapy-in-oligometastatic-nsclc/ 2025-10-27T18:33:22+00:00 https://www.tempus.com/news/pr/tempus-to-participate-in-the-stifel-2025-healthcare-conference/ 2025-10-28T12:30:37+00:00 https://www.tempus.com/publications/mutant-and-wild-type-ras-crosstalk-and-stoichiometric-deficiencies-are-determinants-of-sensitivity-to-targeted-therapies-in-krasg12r-2-pancreatic-ductal-adenocarcinoma/ 2025-10-27T18:43:05+00:00 https://www.tempus.com/publications/actionable-mutation-profiles-and-survival-outcomes-in-invasive-mucinous-adenocarcinoma-of-the-lung/ 2025-10-27T18:57:48+00:00 https://www.tempus.com/resources/content/webinars/uncovering-the-uncommon-in-rare-cancers-diagnostic-innovation-driving-change-2/ 2025-10-28T16:49:37+00:00 https://www.tempus.com/wp-content/uploads/2025/08/Webinar_Uncovering-the-uncommon.png https://www.tempus.com/resources/content/webinars/ai-in-oncology-fundamentals-to-full-integration-into-your-practice/ 2025-10-28T16:51:55+00:00 https://www.tempus.com/wp-content/uploads/2025/09/Webinar_AI-in-oncology-fundamentals.png https://www.tempus.com/resources/content/webinars/whats-next-in-oncology-research-breakthroughs-from-the-2025-asco-annual-meeting/ 2025-10-28T16:52:30+00:00 https://www.tempus.com/wp-content/uploads/2025/08/Webinar_Uncovering-the-uncommon.png https://www.tempus.com/resources/content/webinars/industry-expert-theater-presentation-from-the-2025-asco-annual-meeting/ 2025-10-28T16:56:18+00:00 https://www.tempus.com/wp-content/uploads/2025/06/Webinar_IET-ASCO-2025.png https://www.tempus.com/resources/content/webinars/alterations-drive-decisions-advancing-personalized-care-with-comprehensive-genomic-profiling/ 2025-10-28T16:57:13+00:00 https://www.tempus.com/wp-content/uploads/2025/04/Webinar_Alterations-drive-decisions.png https://www.tempus.com/resources/content/webinars/one-blood-sample-many-options-the-benefits-of-tumor-and-normal-match/ 2025-10-28T16:57:43+00:00 https://www.tempus.com/wp-content/uploads/2025/04/Webinar_One-blood-sample-many-options.png https://www.tempus.com/resources/content/webinars/harnessing-the-power-of-ai-optimizing-workflows-enhancing-testing-across-the-cancer-care-continuum/ 2025-10-28T16:59:57+00:00 https://www.tempus.com/wp-content/uploads/2023/05/Tempus-webinar_nP-PGx.jpg https://www.tempus.com/resources/content/webinars/liquid-biopsys-role-in-biomarker-driven-nsclc-management/ 2025-10-28T17:00:45+00:00 https://www.tempus.com/wp-content/uploads/2024/04/Vanderbilt.png https://www.tempus.com/resources/content/webinars/leveraging-rna-sequencing-to-identify-actionable-biomarkers-in-nsclc-management/ 2025-10-28T17:01:10+00:00 https://www.tempus.com/wp-content/uploads/2024/04/Ochsner-Health.png https://www.tempus.com/resources/content/webinars/evidence-guidelines-based-application-of-pgx-in-mental-health/ 2025-10-28T17:01:31+00:00 https://www.tempus.com/wp-content/uploads/2023/05/Tempus-webinar_nP-PGx.jpg https://www.tempus.com/resources/content/webinars/evolving-standards-precision-medicine/ 2025-10-28T17:05:21+00:00 https://www.tempus.com/resources/content/webinars/operational-processes-and-challenges/ 2025-10-28T17:07:42+00:00 https://www.tempus.com/wp-content/uploads/2021/12/ep6-onclive-preview.jpeg https://www.tempus.com/resources/content/webinars/role-of-ctdna-in-germline-testing/ 2025-10-28T17:08:13+00:00 https://www.tempus.com/wp-content/uploads/2021/12/ep5-onclive-preview.jpeg https://www.tempus.com/resources/content/webinars/identification-of-patients-for-germline-testing/ 2025-10-28T17:08:43+00:00 https://www.tempus.com/wp-content/uploads/2021/12/ep4-onclive-preview.jpeg https://www.tempus.com/resources/content/webinars/experience-with-interpreting-somatic-reports/ 2025-10-28T17:09:51+00:00 https://www.tempus.com/wp-content/uploads/2021/12/ep3-onclive-preview.jpeg https://www.tempus.com/resources/content/webinars/tumor-normal-matched-sequencing-and-platforms-utilized-for-tumor-profiling/ 2025-10-28T17:10:28+00:00 https://www.tempus.com/wp-content/uploads/2021/12/ep2-onclive-preview.jpeg https://www.tempus.com/resources/content/webinars/defining-germline-sequencing-and-incidental-germline-findings-july-22-2021/ 2025-10-28T17:11:08+00:00 https://www.tempus.com/wp-content/uploads/2021/12/ep1-onclive-preview.jpeg https://www.tempus.com/resources/content/webinars/how-to-reduce-your-documentation-burden-with-ai/ 2025-10-28T18:23:34+00:00 https://www.tempus.com/wp-content/uploads/2025/10/Webinar_How-to-reduce-your-documentation-burden-with-AI.png https://www.tempus.com/resources/content/webinars/scientific-breakthroughs-across-the-cancer-continuum-research-from-the-2024-asco-annual-meeting/ 2025-10-28T18:29:33+00:00 https://www.tempus.com/wp-content/uploads/2023/05/Tempus-webinar_nP-PGx.jpg https://www.tempus.com/resources/content/webinars/tempus-fda-approval-insights-use-companion-diagnostics-clinical-development/ 2025-10-28T18:35:41+00:00 https://www.tempus.com/wp-content/uploads/2022/07/Tempus-webinar_nP-PGx.png https://www.tempus.com/resources/content/webinars/harnessing-real-world-genomics-data-to-power-precision-medicine/ 2025-10-28T18:40:09+00:00 https://www.tempus.com/resources/content/webinars/enhancing-psychiatric-care-with-pharmacogenomics-pgx/ 2025-10-28T18:51:13+00:00 https://www.tempus.com/wp-content/uploads/2023/05/Tempus-webinar_nP-PGx.jpg https://www.tempus.com/resources/content/webinars/discover-novel-targets-and-applications-with-tempus-explore/ 2025-10-28T18:56:10+00:00 https://www.tempus.com/resources/content/webinars/transforming-immunotherapy-with-tempus/ 2025-10-28T19:07:17+00:00 https://www.tempus.com/wp-content/uploads/2022/07/Tempus-webinar_nP-PGx.png https://www.tempus.com/news/tempus-reports-third-quarter-2025-results/ 2025-11-04T21:00:41+00:00 https://www.tempus.com/wp-content/uploads/2025/11/T1.png https://www.tempus.com/wp-content/uploads/2025/11/IS.png https://www.tempus.com/wp-content/uploads/2025/11/BS-1.2.png https://www.tempus.com/wp-content/uploads/2025/11/BS-2.png https://www.tempus.com/wp-content/uploads/2025/11/SCF-1.png https://www.tempus.com/wp-content/uploads/2025/11/SCF-2.png https://www.tempus.com/wp-content/uploads/2025/11/SCF-3.png https://www.tempus.com/wp-content/uploads/2025/11/T2.png https://www.tempus.com/wp-content/uploads/2025/11/T3.png https://www.tempus.com/wp-content/uploads/2025/11/T4.png https://www.tempus.com/wp-content/uploads/2025/11/T5.png https://www.tempus.com/wp-content/uploads/2025/11/T6.png https://www.tempus.com/wp-content/uploads/2025/11/T7.png https://www.tempus.com/wp-content/uploads/2025/11/T8.png https://www.tempus.com/news/pr/tempus-announces-six-abstracts-accepted-for-presentation-at-the-society-for-immunotherapy-of-cancer-annual-meeting-2025/ 2025-11-05T15:17:47+00:00 https://www.tempus.com/resources/content/webinars/the-rna-advantage-a-multimodal-approach-to-accelerating-oncology-rd/ 2025-11-05T17:07:46+00:00 https://www.tempus.com/wp-content/uploads/2025/05/Webinar_The-RNA-advantage.png https://www.tempus.com/resources/content/case-studies/maximizing-precision-in-pathology-the-critical-path-approach/ 2025-11-05T21:00:55+00:00 https://www.tempus.com/wp-content/uploads/2025/11/Case-Study_Maximizing-precision-in-pathology-with-AI.jpg https://www.tempus.com/publications/molecular-characterization-of-oncogenic-gene-fusions-in-a-large-real-world-cohort-of-solid-tumors/ 2025-11-07T19:42:01+00:00 https://www.tempus.com/resources/content/webinars/beyond-imaging-leveraging-molecular-tools-to-detect-mrd-for-personalized-cancer-care/ 2025-11-07T22:31:47+00:00 https://www.tempus.com/wp-content/uploads/2025/11/Webinar_Beyond-imaging-leveraging-molecular-tools-to-detect-mrd-for-personalized-cancer-care.png https://www.tempus.com/publications/target-rna-expression-by-tumor-molecular-subtypes-in-patients-pts-with-advanced-urothelial-carcinoma-auc-or-muscle-invasive-bladder-cancer-mibc-exploratory-analyses-from-javelin-bladder-100-and/ 2025-11-12T20:28:43+00:00 https://www.tempus.com/wp-content/uploads/2025/11/Screenshot-2025-11-12-at-2.18.50-PM.png https://www.tempus.com/publications/longitudinal-changes-in-circulating-tumor-dna-in-a-phase-i-dose-escalation-study-of-micvotabart-pelidotin-a-first-in-human-adc-targeting-edbfn/ 2025-11-12T20:37:50+00:00 https://www.tempus.com/publications/real-world-molecular-epidemiology-study-of-select-biomarkers-in-extensive-stage-small-cell-lung-cancer-es-sclc/ 2025-11-12T20:50:09+00:00 https://www.tempus.com/wp-content/uploads/2025/11/Screenshot-2025-11-12-at-2.48.40-PM.png https://www.tempus.com/publications/efficacy-of-cabozantinib-and-nivolumab-in-cluster-1-2-metastatic-clear-cell-renal-cell-carcinoma-results-from-optic-rcc-a-phase-ii-trial-of-a-novel-rnaseq-based-biomarker/ 2025-11-12T21:06:48+00:00 https://www.tempus.com/publications/lymphocyte-activation-gene-3-lag3-expression-patterns-and-immunotherapy-io-response-in-metastatic-renal-cell-carcinoma-mrcc/ 2025-11-12T21:18:22+00:00 https://www.tempus.com/wp-content/uploads/2025/11/Screenshot-2025-11-12-at-3.15.15-PM.png https://www.tempus.com/publications/impact-of-tumor-suppressor-gene-tsg-alteration-alt-burden-on-outcomes-in-patients-pts-with-metastatic-castration-sensitive-prostate-cancer-mcspc/ 2025-11-12T21:25:11+00:00 https://www.tempus.com/wp-content/uploads/2025/11/Screenshot-2025-11-12-at-3.21.43-PM.png https://www.tempus.com/publications/immunodriver-2-cd8-t-cell-and-pd-l1-levels-associate-with-first-line-1l-overall-survival-os-in-immune-checkpoint-inhibition-ici-treated-non-small-cell-lung-cancer-nsclc/ 2025-11-12T21:29:56+00:00 https://www.tempus.com/wp-content/uploads/2025/11/Screenshot-2025-11-12-at-3.27.33-PM.png https://www.tempus.com/publications/real-world-analyses-to-evaluate-the-role-of-tigit-as-a-target-in-first-line-1l-metastatic-non-small-cell-lung-cancer-mnsclc/ 2025-11-12T21:37:37+00:00 https://www.tempus.com/publications/the-association-between-tumor-immunogenomic-features-and-first-line-1l-therapeutic-outcomes-in-advanced-biliary-tract-cancer-btc/ 2025-11-12T21:47:10+00:00 https://www.tempus.com/wp-content/uploads/2025/11/Screenshot-2025-11-12-at-3.45.13-PM.png https://www.tempus.com/publications/unveiling-integrin-beta-6-ib6-real-world-data-from-the-ib6-expression-and-clinical-outcomes-in-non-small-cell-lung-cancer-study/ 2025-11-12T21:50:39+00:00 https://www.tempus.com/publications/genomic-landscape-and-outcomes-of-renal-cell-carcinoma-with-metastases-to-the-pancreas/ 2025-11-12T21:57:24+00:00 https://www.tempus.com/publications/analysis-of-prame-in-advanced-metastatic-solid-tumors-shows-homogeneous-expression-and-stability-between-lesions-across-treatment-lines-and-upon-exposure-to-checkpoint-inhibitors/ 2025-11-13T20:21:42+00:00 https://www.tempus.com/publications/the-estimated-long-term-clinical-effects-of-brca-testing-and-olaparib-treatment-of-early-breast-cancer-in-the-us-population-a-population-impact-model/ 2025-11-13T20:46:32+00:00 https://www.tempus.com/publications/intersection-of-black-race-and-carbohydrate-antigen-19-9-nonproduction-underpins-worse-pathologic-response-to-neoadjuvant-therapy-in-pancreatic-cancer/ 2025-11-13T20:54:00+00:00 https://www.tempus.com/news/tempus-and-ifli-announce-study-to-advance-follicular-lymphoma-research/ 2025-11-14T13:30:34+00:00 https://www.tempus.com/publications/impact-of-ras-braf-v600e-mutations-on-the-tumor-immune-microenvironment-in-mismatch-repair-deficient-microsatellite-instability-colorectal-cancers/ 2025-11-17T17:46:19+00:00 https://www.tempus.com/news/tempus-to-participate-in-the-piper-sandler-37th-annual-healthcare-conference/ 2025-11-18T13:30:14+00:00 https://www.tempus.com/publications/translating-deep-learning-to-clinical-practice-external-validation-and-clinical-benefit-of-an-electrocardiogram-based-neural-network-for-detecting-low-ejection-fraction/ 2025-11-24T18:13:46+00:00 https://www.tempus.com/resources/content/webinars/a-new-era-of-biopharma-rd/ 2025-11-24T22:45:20+00:00 https://www.tempus.com/wp-content/uploads/2025/11/Webinar_A-new-era-of-Biopharma-RD.png https://www.tempus.com/publications/targetr-automated-multi-omics-report-framework-for-target-characterization-and-validation-of-immunotherapy-and-targeted-therapy-candidates-across-cancers/ 2025-11-26T17:26:05+00:00 https://www.tempus.com/publications/a-multi-omic-immune-profile-score-ips-stratifies-real-world-outcomes-of-microsatellite-stable-mss-advanced-colorectal-cancer-patients-treated-with-immune-checkpoint-inhibitors/ 2025-11-26T17:27:28+00:00 https://www.tempus.com/publications/a-novel-multi-omic-algorithm-to-predict-real-world-outcomes-among-patients-with-rare-advanced-solid-cancers-treated-with-off-label-immune-checkpoint-inhibitors/ 2025-11-26T17:28:36+00:00 https://www.tempus.com/publications/impact-of-androgen-receptor-mutations-on-immune-infiltration-in-castration-resistant-prostate-cancer/ 2025-11-26T17:30:35+00:00 https://www.tempus.com/publications/ultrahigh-tumor-mutational-burden-tmb-is-associated-with-improved-survival-outcomes-in-patients-pts-treated-with-immune-checkpoint-inhibitors-icis/ 2025-11-26T17:31:43+00:00 https://www.tempus.com/wp-content/uploads/2025/11/Screenshot-2025-11-13-at-2.15.31-PM.png https://www.tempus.com/wp-content/uploads/2025/11/F1.large_.jpg https://www.tempus.com/publications/mait-cell-abundance-within-solid-tumors-is-associated-with-key-clinical-characteristics/ 2025-11-26T17:32:55+00:00 https://www.tempus.com/wp-content/uploads/2025/11/1.jpg https://www.tempus.com/wp-content/uploads/2025/11/2.jpg https://www.tempus.com/resources/content/articles/qa-uncovering-the-uncommon-in-rare-cancers/ 2025-12-01T15:32:35+00:00 https://www.tempus.com/wp-content/uploads/2025/11/QA_Uncovering-the-uncommon-in-rare-cancers.jpg https://www.tempus.com/publications/establishing-cerebral-arterial-blood-flow-baselines-in-healthy-individuals-using-non-contrast-4d-flow-mri/ 2025-12-05T18:54:43+00:00 https://www.tempus.com/publications/evaluation-of-the-1021-hrd-assay-compared-to-established-hrd-testing-platforms-in-ovarian-cancer/ 2025-12-05T18:59:55+00:00 https://www.tempus.com/publications/examining-tp53-mutated-plasma-cell-disorders-across-the-disease-spectrum-using-broad-next-generation-sequencing/ 2025-12-08T21:31:56+00:00 https://www.tempus.com/news/tempus-announces-ten-abstracts-accepted-for-presentation-at-the-2025-san-antonio-breast-cancer-symposium/ 2025-12-09T13:30:09+00:00 https://www.tempus.com/resources/content/webinars/pioneering-decentralized-oncology-trials-success-at-the-nations-largest-community-practices/ 2025-12-15T16:29:15+00:00 https://www.tempus.com/wp-content/uploads/2025/12/Webinar_Pioneering-decentralized-oncology-trials.png https://www.tempus.com/publications/whole-genome-sequencing-uncovers-novel-bcrabl1-breakpoints-and-variants-in-leukemia-implications-for-personalized-medicine/ 2025-12-15T16:35:16+00:00 https://www.tempus.com/publications/the-chromatin-remodeling-protein-arid1a-is-required-for-mll-af9-leukemogenesis/ 2025-12-15T16:36:22+00:00 https://www.tempus.com/resources/content/webinars/driving-enterprise-value-with-rwd/ 2025-12-15T16:41:54+00:00 https://www.tempus.com/wp-content/uploads/2025/12/Webinar_Driving-enterprise-value-with-rwd.png https://www.tempus.com/publications/a-concordance-study-among-26-ngs-laboratories-participating-in-the-national-cancer-institute-molecular-analysis-for-therapy-choice-nci-match-clinical-trial/ 2025-12-23T22:41:23+00:00 https://www.tempus.com/news/pr/tempus-to-present-at-44th-annual-j-p-morgan-healthcare-conference/ 2026-01-06T13:30:38+00:00 https://www.tempus.com/publications/genetic-configurations-and-liver-niche-drive-tumor-intrinsic-state-plasticity-in-metastatic-mss-crc/ 2026-01-05T22:49:55+00:00 https://www.tempus.com/publications/a-real-world-study-of-claudin-18-2-cldn18-2-association-with-molecular-subtypes-mutations-biomarkers-immune-landscapes-and-gene-signatures-and-prognostic-value-in-pancreatic-ductal-adenocarcinoma/ 2026-01-05T22:53:24+00:00 https://www.tempus.com/wp-content/uploads/2026/01/Screenshot-2026-01-05-at-4.51.43-PM.png https://www.tempus.com/publications/baseline-biomarker-analysis-and-clinical-outcomes-of-the-pd-1-tgf%ce%b2r2-bispecific-antibody-inca33890-in-patients-with-non-msi-h-metastatic-colorectal-cancer-mcrc/ 2026-01-05T23:01:05+00:00 https://www.tempus.com/wp-content/uploads/2026/01/Screenshot-2026-01-05-at-4.59.42-PM.png https://www.tempus.com/publications/genomic-characteristics-clinical-profiling-and-outcomes-of-advanced-pancreatic-ductal-adenocarcinoma-pdac-with-mtap-deletion-mtap-del-analyses-from-a-multimodal-real-world-dataset/ 2026-01-05T23:04:02+00:00 https://www.tempus.com/news/pr/tempus-announces-eight-abstracts-accepted-for-presentation-at-the-2026-asco-gastrointestinal-cancers-symposium/ 2026-01-08T13:30:38+00:00 https://www.tempus.com/publications/germline-alterations-in-patients-with-lung-cancer-2/ 2026-01-08T17:51:22+00:00 https://www.tempus.com/publications/clinical-echocardiographic-and-socioeconomic-predictors-of-progression-and-outcomes-in-patients-with-moderate-aortic-stenosis-2/ 2026-01-08T17:57:50+00:00 https://www.tempus.com/publications/a-randomized-trial-evaluating-automated-notifications-for-the-identification-and-treatment-of-aortic-stenosis-and-mitral-regurgitation-the-alert-study/ 2026-01-08T18:07:26+00:00 https://www.tempus.com/publications/toward-a-better-pan-tumor-predictive-signature-for-unleashing-precision-immuno-oncology/ 2026-01-08T18:16:11+00:00 https://www.tempus.com/publications/targeted-therapies-and-parpi-therapy-response-following-ici-therapy-failure-in-advanced-melanoma-a-case-series/ 2026-01-08T18:29:51+00:00 https://www.tempus.com/publications/impact-of-kras-codon-specific-mutations-on-survival-in-metastatic-crc-on-trifluridine-tipiracil-with-without-bevacizumab/ 2026-01-08T19:05:56+00:00 https://www.tempus.com/publications/sclerosing-melanocytic-tumors-with-map2k1-in-frame-deletions-and-15q-gains-a-distinctive-pathway-of-nevogenesis-with-reproducible-morphology/ 2026-01-08T19:11:42+00:00 https://www.tempus.com/publications/the-impact-of-next-generation-sequencing-on-interobserver-agreement-and-diagnostic-accuracy-of-deep-penetrating-melanocytic-neoplasms/ 2026-01-08T19:23:06+00:00 https://www.tempus.com/publications/characterisation-of-the-immunogenomic-landscape-of-ovarian-cancer-uncovers-a-distinct-subset-of-endometroid-tumours-associated-with-high-cst2-expression-and-a-favourable-prognosis/ 2026-01-08T19:26:53+00:00 https://www.tempus.com/news/tempus-and-nyu-langone-health-announce-strategic-research-collaboration-to-advance-precision-oncology/ 2026-01-12T13:30:29+00:00 https://www.tempus.com/news/northwestern-medicine-selects-tempus-to-expand-genomic-testing/ 2026-01-12T12:00:05+00:00 https://www.tempus.com/news/tempus-achieves-record-total-contract-value-exceeding-1-1-billion/ 2026-01-11T22:30:32+00:00 https://www.tempus.com/news/tempus-announces-preliminary-fourth-quarter-and-full-year-2025-results/ 2026-01-12T13:59:48+00:00 https://www.tempus.com/publications/advanced-pancreatic-adenocarcinoma-outcomes-in-patients-with-ddr-deficiencies-outside-of-brca1-2-and-palb2/ 2026-01-12T16:27:40+00:00 https://www.tempus.com/publications/genomic-profiling-of-epithelial-neoplasms-of-the-appendix-insights-across-histological-subtypes-and-histological-grades/ 2026-01-12T16:28:33+00:00 https://www.tempus.com/wp-content/uploads/2026/01/Screenshot-2026-01-05-at-3.30.12-PM.png https://www.tempus.com/publications/impact-of-claudin-1-cldn1-expression-on-molecular-correlates-and-clinical-outcomes-in-patients-with-advanced-biliary-tract-cancers-btcs/ 2026-01-12T16:29:40+00:00 https://www.tempus.com/publications/multiomic-analysis-and-oncologic-outcomes-in-pancreatic-cancer-by-pin1-expression/ 2026-01-12T16:30:34+00:00 https://www.tempus.com/wp-content/uploads/2026/01/Screenshot-2026-01-05-at-3.50.27-PM.png https://www.tempus.com/publications/use-of-transcriptomic-signatures-of-rad51-and-gata6-predict-improved-real-world-overall-survival-with-platinum-therapy-in-brca-palb2-wild-type-metastatic-pancreatic-cancer/ 2026-01-12T16:59:30+00:00 https://www.tempus.com/wp-content/uploads/2026/01/Screenshot-2026-01-05-at-3.51.22-PM.png https://www.tempus.com/publications/molecular-characterization-of-resected-non-metastatic-pancreatic-cancer-pc-based-on-kras-status/ 2026-01-12T17:00:14+00:00 https://www.tempus.com/publications/molecular-and-immune-landscape-of-early-onset-versus-average-onset-well-differentiated-enteropancreatic-neuroendocrine-tumors/ 2026-01-12T17:02:34+00:00 https://www.tempus.com/publications/coupling-tumor-genomics-whole-transcriptome-sequencing-and-patient-outcomes-to-define-the-tumor-microenvironment-in-receptor-tyrosine-amplified-gastrointestinal-cancers-analysis-from-24598-cases/ 2026-01-12T17:03:14+00:00 https://www.tempus.com/resources/content/articles/qa-how-techbio-and-multimodal-data-are-reshaping-rd/ 2026-01-12T21:02:54+00:00 https://www.tempus.com/wp-content/uploads/2025/12/QA_-How-techbio-and-multimodal-data-are-reshaping-rd.jpg https://www.tempus.com/publications/patient-records-to-timelines-a-llm-based-approach-for-summarizing-oncology-patient-history/ 2026-01-13T18:56:53+00:00 https://www.tempus.com/resources/content/articles/qa-implementing-successful-decentralized-oncology-trials/ 2026-01-14T15:21:41+00:00 https://www.tempus.com/wp-content/uploads/2026/01/2026-01_QA_Implementing-successful-decentralized-oncology-trials.jpg https://www.tempus.com/publications/genetic-profiling-of-mammary-periductal-stromal-tumors-with-histologic-correlation-highlights-high-grade-and-low-grade-groups-and-similarities-to-phyllodes-tumors/ 2026-01-20T16:40:28+00:00 https://www.tempus.com/publications/pathogenicity-assessment-of-a-tsc2-c-29661ga-splice-site-variant-in-vaginal-adenocarcinoma/ 2026-01-20T16:43:28+00:00 https://www.tempus.com/news/pr/tempus-announces-the-launch-of-paige-predict/ 2026-01-21T14:22:55+00:00 https://www.tempus.com/news/tempus-reveals-its-ai-driven-ips-test-more-accurately-predicts-immunotherapy-benefit-compared-to-conventional-biomarkers/ 2026-01-27T13:30:03+00:00 https://www.tempus.com/resources/content/articles/beyond-the-blueprint-a-scientific-deep-dive-on-rnas-role-in-adc-strategy/ 2026-01-27T22:04:21+00:00 https://www.tempus.com/wp-content/uploads/2026/01/Beyond-the-blueprint-a-scientific-deep-dive-on-rnas-role-in-adc-strategy.jpg https://www.tempus.com/publications/impact-of-large-language-models-on-trial-to-patient-matching-efficiency/ 2026-01-29T15:15:51+00:00 https://www.tempus.com/publications/multi-omic-analysis-of-1001-gist-tumors-reveals-immune-enriched-subtypes/ 2026-02-02T20:13:14+00:00 https://www.tempus.com/wp-content/uploads/2026/02/Screenshot-2026-02-02-at-2.10.48-PM.png https://www.tempus.com/publications/shared-prame-epitopes-are-t-cell-targets-in-nut-carcinoma/ 2026-02-09T16:35:32+00:00 https://www.tempus.com/news/pr/tempus-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-24/ 2026-02-10T13:30:05+00:00 https://www.tempus.com/resources/content/articles/using-an-ai-algorithm-to-predict-possible-msi-high-status-in-prostate-cancer-patients-from-digital-pathology-images/ 2026-02-11T23:46:06+00:00 https://www.tempus.com/wp-content/uploads/2024/04/Using-an-AI-algorithm-to-predict-possible-MSI-high-status-in-prostate-cancer-patients-from-digital-pathology-images-thumb.png https://www.tempus.com/resources/content/articles/solving-cancers-tissue-scarcity-problem-how-tempus-uses-ai-models-in-pathology-to-transform-tissue-analysis/ 2026-02-11T23:46:34+00:00 https://www.tempus.com/wp-content/uploads/2025/09/Solving-cancers-tissue-scarcity-problem_-How-Tempus-uses-AI-models-in-pathology-to-transform-tissue-analysis.jpg https://www.tempus.com/wp-content/uploads/2025/09/P-yield-article-image2.png https://www.tempus.com/wp-content/uploads/2025/10/P-yield-article-image4.png https://www.tempus.com/wp-content/uploads/2025/09/P-yield-article-image3.png https://www.tempus.com/resources/content/articles/from-image-to-insight-how-tempus-is-leveraging-ai-to-advance-biomarker-screening-at-scale/ 2026-02-11T23:47:11+00:00 https://www.tempus.com/wp-content/uploads/2026/01/QA_-From-image-to-insight_-How-Tempus-is-leveraging-AI-to-advance-biomarker-screening-at-scale.jpg https://www.tempus.com/wp-content/uploads/2026/01/paige-biomarker-flow.png https://www.tempus.com/screenshot-2026-01-20-at-5-21-38-pm/ https://www.tempus.com/news/pr/tempus-announces-collaboration-with-median-technologies-to-integrate-ai-powered-lung-cancer-screening-into-the-pixel-platform/ 2026-02-12T21:25:33+00:00 https://www.tempus.com/resources/content/webinars/ask-a-scientist-how-to-leverage-novel-datasets-to-answer-complex-research-questions/ 2026-02-16T16:48:44+00:00 https://www.tempus.com/wp-content/uploads/2026/01/Webinar_ask-a-scientist.png https://www.tempus.com/resources/content/articles/reflections-on-the-2021-san-antonio-breast-cancer-symposium-harnessing-the-power-of-data-to-advance-breast-cancer-research-and-benefit-patients/ 2026-02-17T16:07:52+00:00 https://www.tempus.com/wp-content/uploads/2023/02/Tempus_Blog_Blackwell.jpg https://www.tempus.com/resources/content/articles/advancing-immunotherapy-in-oncology/ 2026-02-17T16:08:22+00:00 https://www.tempus.com/wp-content/uploads/2023/02/Tempus_Blog_Lefkofsky.jpg https://www.tempus.com/resources/content/articles/my-takeaways-the-2022-american-association-for-cancer-researchs-annual-meeting/ 2026-02-17T16:08:38+00:00 https://www.tempus.com/wp-content/uploads/2023/02/Tempus_Blog_Blackwell.jpg https://www.tempus.com/resources/content/articles/beyond-the-ehr-building-a-reliable-mortality-endpoint-for-oncology-research/ 2026-02-17T16:09:27+00:00 https://www.tempus.com/wp-content/uploads/2026/02/beyond-the-ehr-building-a-reliable-mortality-endpoint-for-oncology-research.jpg https://www.tempus.com/resources/content/articles/enhancing-first-line-treatment-for-colorectal-cancer-with-genomic-profiling-and-predictive-diagnostics/ 2026-02-17T16:09:28+00:00 https://www.tempus.com/wp-content/uploads/2023/02/Tempus_Blog_Blackwell.jpg https://www.tempus.com/resources/content/articles/my-takeaways-advancing-equitable-cancer-care-through-innovation-at-the-2022-american-society-of-clinical-oncology-asco-annual-meeting/ 2026-02-17T16:09:45+00:00 https://www.tempus.com/wp-content/uploads/2023/02/Tempus_Blog_Chen.jpg https://www.tempus.com/resources/content/articles/precision-medicine-made-real-enhancing-genetic-testing-with-ai-algorithms/ 2026-02-17T16:10:03+00:00 https://www.tempus.com/wp-content/uploads/2023/02/Tempus_Blog_Stumpe.jpg https://www.tempus.com/resources/content/articles/improving-mental-health-outcomes-through-personalized-medicine/ 2026-02-17T16:11:04+00:00 https://www.tempus.com/wp-content/uploads/2023/02/Tempus_Blog_Lefkofsky.jpg https://www.tempus.com/publications/concurrent-glucocorticoid-taper-enables-reintroduction-of-alectinib-after-drug-induced-rash/ 2026-02-17T17:20:57+00:00 https://www.tempus.com/uncategorized/adverse-myocardial-remodeling-in-repaired-tetralogy-of-fallot/ 2026-02-17T19:37:48+00:00 https://www.tempus.com/wp-content/uploads/2026/02/Screenshot-2026-02-17-at-11.30.16-AM.png https://www.tempus.com/publications/signal-to-noise-ratio-in-4d-flow-cmr-sequence-determinants-and-impact-on-kinetic-energy-energy-loss-and-vorticity-insights-from-the-trek-study/ 2026-02-17T19:45:49+00:00 https://www.tempus.com/wp-content/uploads/2026/02/Screenshot-2026-02-17-at-1.44.58-PM.png https://www.tempus.com/wp-content/uploads/2026/02/Screenshot-2026-02-17-at-1.44.29-PM.png https://www.tempus.com/wp-content/uploads/2026/02/1.jpg https://www.tempus.com/news/pr/tempus-announces-novel-pan-cancer-hrd-rna-algorithm/ 2026-02-18T13:30:10+00:00 https://www.tempus.com/resources/content/case-studies/accelerating-a-phase-1-oncology-trial-the-time-networks-impact-on-patient-enrollment/ 2026-02-24T17:25:33+00:00 https://www.tempus.com/wp-content/uploads/2026/02/Case-Study_TIME_network.jpg https://www.tempus.com/news/pr/tempus-reports-fourth-quarter-and-full-year-2025-results/ 2026-02-24T21:01:30+00:00 https://www.tempus.com/wp-content/uploads/2026/02/2025-Q4_T1-1.png https://www.tempus.com/wp-content/uploads/2026/02/2025-Q4_IS-1.png https://www.tempus.com/wp-content/uploads/2026/02/2025-Q4_BS-1.1.png https://www.tempus.com/wp-content/uploads/2026/02/2025-Q4_BS-2.1.png https://www.tempus.com/wp-content/uploads/2026/02/2025-Q4_BS-3.png https://www.tempus.com/wp-content/uploads/2026/02/2025-Q4_SCF-1.1.png https://www.tempus.com/wp-content/uploads/2026/02/2025-Q4_SCF-2.png https://www.tempus.com/wp-content/uploads/2026/02/2025-Q4_SCF-3.png https://www.tempus.com/wp-content/uploads/2026/02/2025-Q4_SCF-4.png https://www.tempus.com/wp-content/uploads/2026/02/2025-Q4_T2.png https://www.tempus.com/wp-content/uploads/2026/02/2025-Q4_T3.png https://www.tempus.com/wp-content/uploads/2026/02/2025-Q4_T4.png https://www.tempus.com/wp-content/uploads/2026/02/2025-Q4_T5.1.png https://www.tempus.com/wp-content/uploads/2026/02/2025-Q4_T6.1.png https://www.tempus.com/wp-content/uploads/2026/02/2025-Q4_T7.1.png https://www.tempus.com/wp-content/uploads/2026/02/2025-Q4_T7-EBITDA_v3.png https://www.tempus.com/wp-content/uploads/2026/02/2025-Q4_T8.2.png https://www.tempus.com/publications/deciphering-resistance-mechanisms-to-fam-trastuzumab-deruxtecan-nxki-in-metastatic-breast-cancer-using-real-world-data/ 2026-02-25T21:19:42+00:00 https://www.tempus.com/publications/associations-between-circulating-tumor-dna-genomic-profiles-and-serum-thymidine-kinase-patterns-in-patients-with-advanced-hormone-receptor-positive-her2-negative-hr-her-breast-cancer-initiating/ 2026-02-25T21:22:41+00:00 https://www.tempus.com/publications/impact-of-her2-status-dynamics-on-fam-trastuzumab-deruxtecan-nxki-treatment-outcomes-in-metastatic-breast-cancer-real-world-insights/ 2026-02-25T21:26:23+00:00 https://www.tempus.com/publications/molecular-characteristics-of-tnbc-and-pathologic-response-to-chemoimmunotherapy-a-focus-on-racial-disparities/ 2026-02-25T21:32:18+00:00 https://www.tempus.com/publications/the-molecular-and-immune-landscape-of-her2-positive-breast-cancer/ 2026-02-25T21:38:30+00:00 https://www.tempus.com/publications/real-world-data-rwd-outcome-analysis-of-esr1-mutation-emergence-in-hr-her2-metastatic-breast-cancer-through-the-continuum-of-standard-of-care-hormonal-therapy/ 2026-02-25T21:42:07+00:00 https://www.tempus.com/publications/real-world-second-line-treatment-use-and-clinical-outcomes-in-patients-with-hr-positive-her2-negative-metastatic-breast-cancer-mbc-and-an-esr1-mutation-esr1m/ 2026-02-25T21:46:07+00:00 https://www.tempus.com/publications/treatment-sequencing-in-hr-her2-metastatic-breast-cancer-and-associated-real-world-outcomes/ 2026-02-25T21:49:58+00:00 https://www.tempus.com/publications/integrative-modeling-of-multimodal-real-world-data-for-improved-risk-stratification-of-first-line-cdk4-6-inhibitor-outcomes-in-patients-with-estrogen-receptor-er-positive-human-epidermal-growth-fact/ 2026-02-25T21:54:00+00:00 https://www.tempus.com/publications/comparative-analysis-of-the-tumor-immune-microenvironment-time-and-primary-and-metastatic-tissue-in-hr-her2-and-triple-negative-breast-cancer-tnbc/ 2026-02-25T21:57:28+00:00 https://www.tempus.com/publications/clinical-and-molecular-landscape-of-esr1-and-pik3ca-co-mutated-hormone-receptor-positive-metastatic-breast-cancer-hr-mbc-insights-from-8626-patients-including-polyclonality-and-tp53-alterations/ 2026-02-25T22:02:27+00:00 https://www.tempus.com/publications/cathepsin-protease-expression-and-therapeutic-outcomes-to-trastuzumab-deruxtecan-t-dxd-in-metastatic-breast-cancer/ 2026-02-25T22:07:44+00:00 https://www.tempus.com/publications/distinct-transcriptional-and-immunosuppressive-microenvironment-signatures-in-pik3ca-and-esr1-mutant-hormone-receptor-positive-hr-her2-metastatic-breast-cancer-mbc/ 2026-02-25T22:13:37+00:00 https://www.tempus.com/news/pr/tempus-to-participate-in-the-morgan-stanley-technology-media-telecom-conference/ 2026-02-26T13:30:01+00:00 https://www.tempus.com/resources/content/articles/qa-driving-scientific-discovery-with-real-world-multimodal-data/ 2026-02-27T16:42:20+00:00 https://www.tempus.com/wp-content/uploads/2026/02/driving-scientific-discovery-with-real-world-multimodal-data.jpg https://www.tempus.com/resources/content/articles/advancing-the-frontier-of-ai-in-healthcare/ 2026-02-27T16:43:05+00:00 https://www.tempus.com/wp-content/uploads/2025/10/Ryan-Fukushima.png https://www.tempus.com/wp-content/uploads/2025/10/Advancing-the-frontier-of-AI-graphic-1.png https://www.tempus.com/resources/content/articles/meet-olivia/ 2026-02-27T17:26:07+00:00 https://www.tempus.com/wp-content/uploads/2023/02/Tempus_Blog_Lefkofsky.jpg https://www.tempus.com/resources/content/articles/building-the-ecg-of-the-future-with-artificial-intelligence/ 2026-02-27T17:26:23+00:00 https://www.tempus.com/wp-content/uploads/2023/02/Tempus_Blog_Fornwalt-Cardiology.jpg https://www.tempus.com/resources/content/articles/unlocking-the-value-of-rna-data/ 2026-02-27T17:28:25+00:00 https://www.tempus.com/wp-content/uploads/2023/02/Tempus_Blog_Fukushima.jpg https://www.tempus.com/resources/content/articles/leveraging-tempus-ai-and-multimodal-data-to-increase-probability-of-technical-success-in-biopharma/ 2026-02-27T17:28:26+00:00 https://www.tempus.com/wp-content/uploads/2023/02/Tempus_Blog_Huerga.jpg https://www.tempus.com/resources/content/articles/welcome-arterys-integrating-medical-imaging-insights-to-drive-better-outcomes-for-patients/ 2026-02-27T17:29:03+00:00 https://www.tempus.com/wp-content/uploads/2023/02/Tempus_Blog_Fukushima.jpg https://www.tempus.com/resources/content/articles/a-patient-centric-approach-to-transforming-healthcare/ 2026-02-27T17:29:04+00:00 https://www.tempus.com/wp-content/uploads/2023/02/Tempus_Blog_Lefkofsky.jpg https://www.tempus.com/resources/content/case-studies/enhanced-biomarker-discovery-and-design/ 2026-03-01T00:18:35+00:00 https://www.tempus.com/wp-content/uploads/2022/07/Tempus-case-study_Seq-Data.png https://www.tempus.com/resources/content/case-studies/how-to-identify-unmet-medical-need-with-tempus-rwd/ 2026-03-01T00:18:53+00:00 https://www.tempus.com/wp-content/uploads/2022/07/Tempus-case-study_Explore.png https://www.tempus.com/resources/content/case-studies/powering-discovery-tempus-multimodal-database/ 2026-03-01T00:19:17+00:00 https://www.tempus.com/wp-content/uploads/2022/07/Tempus-case-study_Elaine-II.png https://www.tempus.com/resources/content/case-studies/de-risk-investment-and-increase-the-probability-of-technical-success-pts-with-tempus/ 2026-03-01T00:19:36+00:00 https://www.tempus.com/wp-content/uploads/2024/04/Case-Study_AstraZeneca-increases-PTS.jpg https://www.tempus.com/resources/content/case-studies/make-quicker-decisions-by-simulating-and-contextualizing-data-with-tempus/ 2026-03-01T00:19:58+00:00 https://www.tempus.com/wp-content/uploads/2024/04/Case-Study_Mirati-KRAS-G12C.jpg https://www.tempus.com/resources/content/case-studies/reduce-time-to-launch-with-tempus-and-multimodal-data/ 2026-03-01T00:20:18+00:00 https://www.tempus.com/wp-content/uploads/2024/04/Case-Study_AstraZeneca-reduces-time-to-launch.jpg https://www.tempus.com/resources/content/case-studies/pfizer-her2-expression/ 2026-03-01T00:20:39+00:00 https://www.tempus.com/wp-content/uploads/2024/04/Case-Study_Pfizer-HER2-Expression.jpg https://www.tempus.com/resources/content/case-studies/guiding-indication-expansion-with-multimodal-real-world-data/ 2026-03-01T00:21:04+00:00 https://www.tempus.com/resources/content/case-studies/validating-a-novel-target-and-informing-trial-design-for-a-first-in-class-therapeutic/ 2026-03-01T00:21:33+00:00 https://www.tempus.com/wp-content/uploads/2025/11/Case-Study_Indication_selection_biomarker_strategy.jpg https://www.tempus.com/resources/content/articles/qa-impact-of-multimodal-data-in-translational-science/ 2026-03-01T00:21:49+00:00 https://www.tempus.com/wp-content/uploads/2023/12/QA_-Impact-of-multimodal-data-in-translational-science-thumb.jpg https://www.tempus.com/resources/content/articles/qa-navigating-tumor-complexity-to-build-confidence-in-new-targets/ 2026-03-01T00:23:40+00:00 https://www.tempus.com/wp-content/uploads/2025/11/QA_-Navigating-tumor-complexity-to-build-confidence-in-new-targets-1.jpg https://www.tempus.com/resources/content/articles/qa-designing-a-modern-cdx-strategy-for-adcs/ 2026-03-01T00:23:54+00:00 https://www.tempus.com/wp-content/uploads/2025/11/QA_-Designing-a-modern-CDx-strategy-for-ADCs.jpg https://www.tempus.com/wp-content/uploads/2025/11/RNA-IHC-graph.png https://www.tempus.com/resources/content/articles/a-new-data-driven-playbook-for-improving-adc-success-rates/ 2026-03-01T00:24:26+00:00 https://www.tempus.com/wp-content/uploads/2025/12/A-new-data-driven-playbook-for-improving-adc-success-rates.jpg https://www.tempus.com/wp-content/uploads/2025/12/World-ADC-2025-graphs.png https://www.tempus.com/resources/content/articles/ai-enabled-data-abstraction-transforms-tempus-data/ 2026-03-01T00:24:42+00:00 https://www.tempus.com/wp-content/uploads/2026/01/2026-1_AI-enabled-data-abstraction-transforms-Tempus-data.jpg https://www.tempus.com/resources/content/articles/how-real-world-data-drives-value-and-de-risks-development/ 2026-03-01T00:24:56+00:00 https://www.tempus.com/wp-content/uploads/2026/01/QA_-How-real-world-data-drives-value-and-de-risks-development.jpg https://www.tempus.com/resources/content/articles/building-the-engine-to-scale-data-abstraction-through-ai/ 2026-03-01T00:25:12+00:00 https://www.tempus.com/wp-content/uploads/2026/02/Building-the-engine-to-scale-data-abstraction-through-ai.jpg https://www.tempus.com/news/pr/tempus-announces-strategic-collaboration-agreement-with-merck-to-accelerate-ai-driven-precision-medicine/ 2026-03-03T13:33:09+00:00 https://www.tempus.com/publications/clinicogenomic-and-immune-profiles-of-male-breast-cancer-by-race-insights-from-a-large-real-world-cohort/ 2026-03-04T15:00:32+00:00 https://www.tempus.com/resources/content/case-studies/supporting-the-financial-health-of-clinical-research-programs-with-the-tempus-time-trial-network/ 2026-03-04T15:12:52+00:00 https://www.tempus.com/wp-content/uploads/2026/03/Case-Study_clinical-research-programs.jpg https://www.tempus.com/publications/opening-the-black-box-biologic-pathways-underlying-multimodal-digital-pathology-artificial-intelligence-in-metastatic-prostate-cancer/ 2026-03-06T15:36:28+00:00 https://www.tempus.com/publications/genomic-characterization-of-upper-tract-urothelial-carcinoma-utuc-with-or-without-sarcomatoid-differentiation/ 2026-03-06T15:43:52+00:00 https://www.tempus.com/publications/real-world-genomic-analysis-of-chemerin-in-prostate-cancer-pca-and-correlation-with-markers-of-immune-infiltration-and-activation/ 2026-03-06T15:44:31+00:00 https://www.tempus.com/publications/molecular-and-clinical-correlates-of-early-onset-clear-cell-renal-cell-carcinoma-eorcc-a-real-world-multi-omics-analysis/ 2026-03-06T15:47:00+00:00 https://www.tempus.com/publications/updated-clinical-results-and-associated-biomarkers-from-an-ongoing-phase-1-study-of-fx-909-a-first-in-class-peroxisome-proliferator-activated-receptor-gamma-pparg-inhibitor-in-patients-pts-with/ 2026-03-06T15:58:55+00:00 https://www.tempus.com/publications/genomic-alterations-and-pathologic-responses-to-neoadjuvant-androgen-receptor-pathway-inhibitor-arpi-doublets-vs-docetaxel-triplets-in-the-genomic-umbrella-neoadjuvant-study-guns/ 2026-03-09T12:03:08+00:00 https://www.tempus.com/resources/content/articles/how-ai-is-impacting-the-drug-discovery-process/ 2026-03-09T16:02:27+00:00 https://www.tempus.com/wp-content/uploads/2026/01/how-ai-is-impacting-the-drug-discovery-process.jpg https://www.tempus.com/resources/content/articles/ai-revolution-electrocardiography-ecg-ai-insights/ 2026-03-09T16:03:12+00:00 https://www.tempus.com/wp-content/uploads/2026/01/how-ai-is-impacting-electrocardiography-and-ecg-interpretation-for-a-more-accurate-diagnosis-of-cardiovascular-diseases.jpg https://www.tempus.com/resources/content/articles/how-ai-impacts-clinical-trial-process-design-matching/ 2026-03-09T16:03:43+00:00 https://www.tempus.com/wp-content/uploads/2026/01/how-ai-is-impacting-the-clinical-trial-process.jpg https://www.tempus.com/resources/content/articles/ai-in-healthcare/ 2026-03-09T16:03:56+00:00 https://www.tempus.com/wp-content/uploads/2026/01/artificial-intelligence-in-healthcare-in-2026-and-beyond.jpg https://www.tempus.com/events/amp-2025/ 2026-03-09T21:21:24+00:00 https://www.tempus.com/events/esmo-congress-2025/ 2026-03-09T21:21:26+00:00 https://www.tempus.com/events/biomarkers-us-2025/ 2026-03-09T21:21:26+00:00 https://www.tempus.com/events/asco-2023/ 2026-03-09T21:21:27+00:00 https://www.tempus.com/events/hpn-2025/ 2026-03-09T21:21:28+00:00 https://www.tempus.com/events/us-oncology-network-hereditary-genetics-and-precision-medicine-conference-2025/ 2026-03-09T21:21:28+00:00 https://www.tempus.com/events/world-adc-2025/ 2026-03-09T21:21:28+00:00 https://www.tempus.com/events/biotechx-usa-2025/ 2026-03-09T21:21:29+00:00 https://www.tempus.com/events/world-cb-cdx-summit-2025/ 2026-03-09T21:21:29+00:00 https://www.tempus.com/events/acc-2025/ 2026-03-09T21:21:30+00:00 https://www.tempus.com/events/asco-2025/ 2026-03-09T21:21:31+00:00 https://www.tempus.com/events/ispor-2025/ 2026-03-09T21:21:31+00:00 https://www.tempus.com/events/pmwc-2025/ 2026-03-09T21:21:33+00:00 https://www.tempus.com/events/liquid-biopsy-for-precision-oncology-summit-2025/ 2026-03-09T21:21:33+00:00 https://www.tempus.com/events/uscap-2025/ 2026-03-09T21:21:33+00:00 https://www.tempus.com/events/sabcs-2024/ 2026-03-09T21:21:34+00:00 https://www.tempus.com/events/world-adc-2024/ 2026-03-09T21:21:35+00:00 https://www.tempus.com/events/sitc-annual-meeting-2024/ 2026-03-09T21:21:35+00:00 https://www.tempus.com/events/nsgc-annual-conference-2024/ 2026-03-09T21:21:36+00:00 https://www.tempus.com/events/biotechx-europe-2024/ 2026-03-09T21:21:36+00:00 https://www.tempus.com/events/esmo-congress-2024/ 2026-03-09T21:21:37+00:00 https://www.tempus.com/events/dpharm-2024/ 2026-03-09T21:21:38+00:00 https://www.tempus.com/events/biotechx-usa-2024/ 2026-03-09T21:21:38+00:00 https://www.tempus.com/events/ras-targeted-drug-development-summit-2024/ 2026-03-09T21:21:38+00:00 https://www.tempus.com/events/world-cb-cdx-2024/ 2026-03-09T21:21:39+00:00 https://www.tempus.com/events/wclc-2024/ 2026-03-09T21:21:39+00:00 https://www.tempus.com/events/aacr-2023/ 2026-03-09T21:21:40+00:00 https://www.tempus.com/events/asco-2024/ 2026-03-09T21:21:40+00:00 https://www.tempus.com/events/rsna-2023/ 2026-03-09T21:21:41+00:00 https://www.tempus.com/events/sabcs-2023/ 2026-03-09T21:21:41+00:00 https://www.tempus.com/events/aacr-annual-meeting-2024/ 2026-03-09T21:21:41+00:00 https://www.tempus.com/events/esmo-congress-2023/ 2026-03-09T21:21:42+00:00 https://www.tempus.com/events/tumor-models-boston-summit-2024/ 2026-03-09T21:21:42+00:00 https://www.tempus.com/events/ddr-inhibitors-summit-2024/ 2026-03-09T21:21:43+00:00 https://www.tempus.com/events/liquid-biopsy-for-precision-oncology-summit-2024/ 2026-03-09T21:21:43+00:00 https://www.tempus.com/events/spatial-biology-for-immuno-oncology-summit-2024/ 2026-03-09T21:21:44+00:00 https://www.tempus.com/events/sitc-2023/ 2026-03-09T21:21:45+00:00 https://www.tempus.com/events/pmwc-2024/ 2026-03-09T21:21:45+00:00 https://www.tempus.com/events/asco-gi-2024/ 2026-03-09T21:21:45+00:00 https://www.tempus.com/events/world-adc-2023/ 2026-03-09T21:21:46+00:00 https://www.tempus.com/events/asco-2022/ 2026-03-09T21:21:47+00:00 https://www.tempus.com/events/biotechx-europe-2023/ 2026-03-09T21:21:47+00:00 https://www.tempus.com/events/spatial-bio-drug-development-2023/ 2026-03-09T21:21:47+00:00 https://www.tempus.com/events/fierce-clinical-summit-2023/ 2026-03-09T21:21:47+00:00 https://www.tempus.com/events/sabcs-2022/ 2026-03-09T21:21:48+00:00 https://www.tempus.com/events/aha-2022/ 2026-03-09T21:21:48+00:00 https://www.tempus.com/events/asco-gi-2023/ 2026-03-09T21:21:49+00:00 https://www.tempus.com/events/asco-gu-2023/ 2026-03-09T21:21:50+00:00 https://www.tempus.com/events/mrna-based-therapeutics2023/ 2026-03-09T21:21:50+00:00 https://www.tempus.com/news/pr/tempus-announces-study-highlighting-the-role-of-advanced-genomic-profiling-features-in-identifying-clinically-actionable-findings/ 2026-03-11T12:30:48+00:00 https://www.tempus.com/resources/content/webinars/ai-ml-in-action-real-time-advances-in-precision-medicine/ 2026-03-11T15:11:36+00:00 https://www.tempus.com/wp-content/uploads/2023/05/Tempus-webinar_nP-PGx.jpg https://www.tempus.com/life-sciences/lens-library/molecular-and-clinical-characterization-of-her2-low-versus-her2-0-breast-cancer/ 2026-03-11T15:11:39+00:00 https://www.tempus.com/wp-content/uploads/2025/10/Lens-Library_Violin-Plot-3.jpg https://www.tempus.com/life-sciences/lens-library/rna-seq-immune-subtyping-to-optimize-immunotherapy-in-mnsclc/ 2026-03-11T15:11:39+00:00 https://www.tempus.com/wp-content/uploads/2025/10/Lens-Library_KM-Curve-2.jpg https://www.tempus.com/life-sciences/lens-library/role-of-chromatin-remodeling-protein-arid1a-in-mll-af9-leukemogenesis/ 2026-03-11T15:11:39+00:00 https://www.tempus.com/wp-content/uploads/2025/10/Lens-Library_KM-Curve.jpg https://www.tempus.com/life-sciences/lens-library/impact-of-b-cell-and-cd8-t-cell-infiltration-on-immunotherapy-outcomes-in-nsclc/ 2026-03-11T15:11:40+00:00 https://www.tempus.com/wp-content/uploads/2025/10/Lens-Library_KM-Curve-3.jpg https://www.tempus.com/life-sciences/lens-library/impact-of-pik3r1-loss-of-function-on-survival-in-metastatic-breast-cancer/ 2026-03-11T15:11:40+00:00 https://www.tempus.com/wp-content/uploads/2025/10/Lens-Library_KM-Curve-2.jpg https://www.tempus.com/life-sciences/lens-library/impact-of-vegf-expression-on-pembrolizumab-outcomes-in-mnsclc/ 2026-03-11T15:11:41+00:00 https://www.tempus.com/wp-content/uploads/2025/10/Lens-Library_KM-Curve.jpg https://www.tempus.com/resources/content/articles/qa-harnessing-ai-with-multimodal-data-to-transform-drug-development/ 2026-03-13T19:38:45+00:00 https://www.tempus.com/wp-content/uploads/2024/11/QA_-Harnessing-AI-with-multimodal-data-to-transform-drug-development.png https://www.tempus.com/wp-content/uploads/2024/11/2024-11_QA-Article-Chart-1.png https://www.tempus.com/resources/content/articles/qa-how-ai-driven-solutions-are-helping-close-care-gaps-in-precision-medicine-adoption/ 2026-03-13T19:43:23+00:00 https://www.tempus.com/wp-content/uploads/2025/07/QA_-How-Tempus-applies-AI-to-advance-clinical-research-and-patient-care.jpg https://www.tempus.com/resources/content/articles/qa-how-tempus-applies-ai-for-clinical-research-and-patient-care/ 2026-03-13T19:46:32+00:00 https://www.tempus.com/wp-content/uploads/2025/07/QA_How-Tempus-applies-AI-to-advance-clinical-research-and-patient-care.jpg https://www.tempus.com/resources/content/articles/using-multimodal-real-world-data-for-decision-making/ 2026-03-13T19:52:32+00:00 https://www.tempus.com/wp-content/uploads/2023/02/Using-multimodal-real-world-data-for-decision-making-thumb.jpg https://www.tempus.com/resources/content/articles/qa-how-cutting-edge-technologies-are-helping-to-advance-precision-medicine/ 2026-03-13T19:54:55+00:00 https://www.tempus.com/wp-content/uploads/2025/04/QA_-How-cutting-edge-technologies-are-helping-to-advance-precision-medicine.png https://www.tempus.com/resources/content/articles/qa-using-ai-to-identify-and-close-gaps-in-care-for-cancer-patients/ 2026-03-13T19:57:07+00:00 https://www.tempus.com/wp-content/uploads/2024/06/QA_-Using-AI-to-Identify-and-Close-Gaps-in-Care-for-Cancer-Patients-thumb.png https://www.tempus.com/resources/content/articles/qa-using-rwd-to-bridge-discovery-and-development-in-translational-research/ 2026-03-13T19:59:33+00:00 https://www.tempus.com/wp-content/uploads/2025/10/QA_-Using-RWD-to-bridge-discovery-and-development-in-translational-research.jpg https://www.tempus.com/resources/content/articles/qa-harnessing-generative-ai-to-refine-clinical-research-drug-development/ 2026-03-13T20:06:23+00:00 https://www.tempus.com/wp-content/uploads/2025/05/QA_-Harnessing-generative-AI-to-refine-clinical-research-drug-development.png https://www.tempus.com/resources/content/articles/qa-connecting-real-world-data-and-organoids-through-tempus-loop/ 2026-03-13T20:07:59+00:00 https://www.tempus.com/wp-content/uploads/2025/04/QA_-Connecting-real-world-data-and-organoids-through-Tempus-Loop.png https://www.tempus.com/resources/content/articles/qa-how-transcriptomics-and-ai-are-accelerating-oncology-rd/ 2026-03-13T20:10:28+00:00 https://www.tempus.com/wp-content/uploads/2025/07/QA_-How-Transcriptomics-and-AI-Are-Accelerating-Oncology-RD.png https://www.tempus.com/publications/unique-features-of-a-comprehensive-genomic-profiling-panel-expanding-treatment-options-in-a-value-based-community-oncology-network/ 2026-03-15T20:49:18+00:00 https://www.tempus.com/resources/content/articles/from-model-to-medicine-closing-the-preclinical-to-clinical-gap-with-an-integrated-data-driven-engine/ 2026-03-16T15:44:57+00:00 https://www.tempus.com/resources/content/articles/beyond-imaging-using-molecular-data-to-personalize-cancer-care/ 2026-03-16T22:03:54+00:00 https://www.tempus.com/wp-content/uploads/2026/03/Beyond-imaging-using-molecular-data-to-personalize-cancer-care.jpg https://www.tempus.com/news/pr/tempus-and-blood-cancer-united-announce-collaboration-to-develop-one-of-the-largest-pediatric-acute-myeloid-leukemia-real-world-data-registries/ 2026-03-17T13:19:04+00:00 https://www.tempus.com/publications/cell-free-testing-reliably-detects-dpyd-and-ugt1a1-pgx-alterations-improving-chemotherapy-dosing-and-clinical-yield/ 2026-03-17T17:04:20+00:00 https://www.tempus.com/publications/piloting-the-forthcoming-acmg-amp-cap-clingen-standards-for-sequence-variant-classification/ 2026-03-17T17:13:41+00:00 https://www.tempus.com/publications/case-report-with-biallelic-variants-in-gcnt2-implicates-exon-1b-in-congenital-cataracts/ 2026-03-17T17:19:03+00:00 https://www.tempus.com/publications/characterization-of-tmem127-related-tumor-predisposition-in-a-hereditary-cancer-cohort/ 2026-03-17T17:24:27+00:00 https://www.tempus.com/publications/impact-of-structural-biology-assessment-on-variant-interpretation-and-patient-outcomes-over-ten-years-in-a-clinical-diagnostic-laboratory/ 2026-03-17T17:32:57+00:00 https://www.tempus.com/publications/to-fibroblast-or-not-to-fibroblast-outcomes-and-clinical-features-of-patients-pursuing-confirmatory-germline-testing-following-tp53-positive-results/ 2026-03-17T17:38:01+00:00 https://www.tempus.com/publications/a-10-year-old-male-with-four-genetic-diagnoses-and-a-complex-multisystem-presentation/ 2026-03-17T17:52:40+00:00 https://www.tempus.com/publications/hifi-long-read-wgs-sequencing-performance-of-buccal-saliva-samples-and-estimation-of-non-human-dna-contamination-from-unaligned-hifi-reads/ 2026-03-17T17:59:17+00:00 https://www.tempus.com/publications/multiple-variant-men1-haplotypes-observed-in-multiple-endocrine-neoplasia-type-1/ 2026-03-17T18:03:12+00:00 https://www.tempus.com/publications/never-stop-looking-dual-diagnoses-due-to-updated-gene-disease-relationships-in-exome-patients/ 2026-03-17T18:07:01+00:00 https://www.tempus.com/publications/obesity-among-patients-with-chromosome-22q11-duplication-syndrome/ 2026-03-17T18:13:49+00:00 https://www.tempus.com/publications/use-of-pangenome-reference-improves-variant-calling-in-clinical-genome-sequencing/ 2026-03-17T18:17:51+00:00 https://www.tempus.com/publications/fractional-clues-decoding-nf1-variant-pathogenicity-through-low-variant-allele-fraction/ 2026-03-17T18:22:04+00:00 https://www.tempus.com/publications/the-other-half-of-the-story-high-rates-of-unique-parental-secondary-finding/ 2026-03-17T18:28:23+00:00 https://www.tempus.com/publications/independent-real-world-application-of-a-clinical-grade-automated-prostate-cancer-detection-system/ 2026-03-17T18:50:36+00:00 https://www.tempus.com/publications/an-independent-assessment-of-an-artificial-intelligence-system-for-prostate-cancer-detection-shows-strong-diagnostic-accuracy/ 2026-03-17T18:57:38+00:00 https://www.tempus.com/publications/artificial-intelligence-assisted-cancer-diagnosis-improves-the-efficiency-of-pathologists-in-prostatic-biopsies/ 2026-03-17T19:00:12+00:00 https://www.tempus.com/publications/clinical-validation-of-artificial-intelligence-augmented-pathology-diagnosis-demonstrates-significant-gains-in-diagnostic-accuracy-in-prostate-cancer-detection/ 2026-03-17T19:08:53+00:00 https://www.tempus.com/publications/artificial-intelligence-helps-pathologists-increase-diagnostic-accuracy-and-efficiency-in-the-detection-of-breast-cancer-lymph-node-metastases/ 2026-03-17T19:18:31+00:00 https://www.tempus.com/publications/a-foundation-model-for-clinical-grade-computational-pathology-and-rare-cancers-detection/ 2026-03-17T19:22:48+00:00 https://www.tempus.com/publications/prospective-clinical-implementation-of-paige-prostate-detect-artificial-intelligence-assistance-in-the-detection-of-prostate-cancer-in-prostate-biopsies-confident-p-trial-implementation-of-artificial/ 2026-03-17T19:29:13+00:00 https://www.tempus.com/publications/using-artificial-intelligence-to-prioritize-pathology-samples-report-of-a-test-drive/ 2026-03-17T19:31:36+00:00 https://www.tempus.com/resources/content/tempus-io-overview/ 2026-03-18T20:30:14+00:00 https://www.tempus.com/wp-content/uploads/2024/04/Content_Tempus-IO-Overview.jpg https://www.tempus.com/publications/sarcomatoid-transformation-rewires-the-immune-spatial-landscape-and-checkpoint-regulation-in-chromophobe-renal-cell-carcinoma/ 2026-03-18T20:35:22+00:00 https://www.tempus.com/publications/pan-cancer-multi-omic-erbb2-her2-characterization-using-next-generation-sequencing-and-quantitative-proteomics/ 2026-03-18T20:42:48+00:00 https://www.tempus.com/news/pr/tempus-announces-strategic-collaboration-with-daiichi-sankyo-to-advance-ai-driven-biomarker-discovery-and-clinical-differentiation-across-an-adc-clinical-program/ 2026-03-25T12:30:52+00:00 https://www.tempus.com/tech-videos/generative-ai/simplifying-complex-queries-with-lens-cohort-builder/ 2026-03-25T14:21:27+00:00 https://www.tempus.com/wp-content/uploads/2024/03/lens-v2-01.jpeg https://www.tempus.com/tech-videos/tempus-os/innovations-from-tempus-in-clinical-insights-and-decision-support/ 2026-03-25T14:21:41+00:00 https://www.tempus.com/wp-content/uploads/2024/11/Tech-video-series-blog.jpg https://www.tempus.com/tech-videos/avoiding-the-pitfalls-of-rag-by-optimizing-llms-for-precision/ 2026-03-25T14:21:53+00:00 https://www.tempus.com/wp-content/uploads/2024/11/Tech-video-series-blog.jpg https://www.tempus.com/resources/content/webinars/translating-data-into-an-actionable-rd-strategy/ 2026-03-25T15:55:20+00:00 https://www.tempus.com/wp-content/uploads/2026/03/Webinar_biotech-town-hall-2.png https://www.tempus.com/publications/a-novel-phenotyping-pipeline-to-improve-identification-of-patients-with-pulmonary-hypertension-in-electronic-health-records/ 2026-03-25T20:17:32+00:00 https://www.tempus.com/wp-content/uploads/2024/05/g8973_1.png https://www.tempus.com/publications/ecg-based-machine-learning-model-identifies-patients-at-high-risk-for-incident-pulmonary-hypertension/ 2026-03-25T20:18:21+00:00 https://www.tempus.com/wp-content/uploads/2024/05/g9120_1.jpg https://www.tempus.com/publications/structured-ehr-data-underestimates-prevalence-and-misses-large-proportions-of-patients-with-pulmonary-hypertension/ 2026-03-25T20:18:42+00:00 https://www.tempus.com/wp-content/uploads/2024/05/g8974_1.jpg https://www.tempus.com/publications/large-language-models-with-retrieval-augmented-generation-for-zero-shot-disease-phenotyping-2/ 2026-03-25T20:18:58+00:00 https://www.tempus.com/publications/prediction-of-mortality-from-12-lead-electrocardiogram-voltage-data-using-a-deep-neural-network/ 2026-03-25T20:19:14+00:00 https://www.tempus.com/life-sciences/lens-library/investigating-racial-disparities-in-survival-and-pd-l1-expression-in-mnsclc/ 2026-03-26T21:12:40+00:00 https://www.tempus.com/wp-content/uploads/2025/10/Lens-Library_KM-Curve-2-1.jpg https://www.tempus.com/life-sciences/lens-library/transcriptional-and-immune-signatures-of-esr1-and-pik3ca-co-mutations-in-hr-mbc/ 2026-03-26T21:12:43+00:00 https://www.tempus.com/wp-content/uploads/2025/10/Lens-Library_Violin-Plot-2.jpg https://www.tempus.com/life-sciences/lens-library/molecular-and-clinical-landscape-of-esr1-and-pik3ca-co-mutations-in-hr-mbc/ 2026-03-26T21:12:44+00:00 https://www.tempus.com/wp-content/uploads/2025/10/Lens-Library_KM-Curve-4.jpg https://www.tempus.com/life-sciences/lens-library/comparing-molecular-landscapes-of-early-and-average-onset-enteropancreatic-nets/ 2026-03-26T21:12:44+00:00 https://www.tempus.com/wp-content/uploads/2025/10/Lens-Library_Violin-Plot.jpg https://www.tempus.com/life-sciences/lens-library/igsf8-expression-differentially-modifies-response-to-immunotherapy-in-metastatic-melanoma/ 2026-03-26T21:12:45+00:00 https://www.tempus.com/wp-content/uploads/2025/10/Lens-Library_KM-Curve-4.jpg https://www.tempus.com/life-sciences/lens-library/leveraging-multimodal-rwd-to-characterize-intratumor-heterogeneity-in-solid-tumors/ 2026-03-26T21:12:45+00:00 https://www.tempus.com/wp-content/uploads/2025/10/Lens-Library_Bar-Graph-4.jpg https://www.tempus.com/life-sciences/lens-library/dgkz-expression-and-vhl-mutations-in-metastatic-kidney-cancer/ 2026-03-26T21:12:46+00:00 https://www.tempus.com/wp-content/uploads/2025/10/Lens-Library_Violin-Plot.jpg https://www.tempus.com/life-sciences/lens-library/uncovering-resistance-mechanisms-in-adc-treated-urothelial-cancer-with-multimodal-rwd/ 2026-03-26T21:12:47+00:00 https://www.tempus.com/wp-content/uploads/2025/10/Lens-Library_Violin-Plot-3.jpg https://www.tempus.com/life-sciences/lens-library/molecular-subtyping-of-sclc-and-its-implications-for-personalized-treatment-strategies/ 2026-03-26T21:12:47+00:00 https://www.tempus.com/wp-content/uploads/2025/10/Lens-Library_Forest-Plot.jpg https://www.tempus.com/life-sciences/lens-library/hgf-and-met-expression-predicts-survival-in-hpv-negative-head-and-neck-cancer/ 2026-03-26T21:12:48+00:00 https://www.tempus.com/wp-content/uploads/2025/10/Lens-Library_KM-Curve-3.jpg https://www.tempus.com/life-sciences/lens-library/evaluating-kras-mutant-allele-dosage-impact-on-first-line-pdac-outcomes/ 2026-03-26T21:12:48+00:00 https://www.tempus.com/wp-content/uploads/2025/10/Lens-Library_KM-Curve-4.jpg https://www.tempus.com/life-sciences/lens-library/predicting-palbociclib-efficacy-in-breast-cancer-with-organoid-derived-biomarkers/ 2026-03-26T21:12:49+00:00 https://www.tempus.com/wp-content/uploads/2025/10/Lens-Library_KM-Curve-2.jpg https://www.tempus.com/life-sciences/lens-library/transcriptomic-profiles-of-treatment-resistance-in-1l-mcrc/ 2026-03-26T21:12:50+00:00 https://www.tempus.com/wp-content/uploads/2025/10/Lens-Library_Violin-Plot-3.jpg https://www.tempus.com/life-sciences/lens-library/defining-high-risk-mcspc-through-tumor-suppressor-gene-burden/ 2026-03-26T21:12:50+00:00 https://www.tempus.com/wp-content/uploads/2025/10/Lens-Library_KM-Curve-2.jpg https://www.tempus.com/life-sciences/lens-library/unveiling-integrin-beta-6-prevalence-in-nsclc-with-real-world-data/ 2026-03-26T21:12:51+00:00 https://www.tempus.com/wp-content/uploads/2025/10/Lens-Library_Bar-Graph-2.jpg https://www.tempus.com/life-sciences/lens-library/analyzing-immunogenomic-predictors-of-ici-response-in-biliary-tract-cancer/ 2026-03-26T21:12:51+00:00 https://www.tempus.com/wp-content/uploads/2025/10/Lens-Library_Violin-Plot.jpg https://www.tempus.com/life-sciences/lens-library/predicting-outcomes-in-nsclc-with-combined-cd8-and-pd-l1-biomarkers/ 2026-03-26T21:12:52+00:00 https://www.tempus.com/wp-content/uploads/2025/10/Lens-Library_KM-Curve-3.jpg https://www.tempus.com/life-sciences/lens-library/9p21-loss-and-low-interferon-expression-predict-poor-ici-response-in-nsclc/ 2026-03-26T21:12:53+00:00 https://www.tempus.com/wp-content/uploads/2025/10/Lens-Library_Violin-Plot-2.jpg https://www.tempus.com/life-sciences/lens-library/investigating-lag-3-expression-as-a-biomarker-in-mrcc-with-multimodal-data/ 2026-03-26T21:12:53+00:00 https://www.tempus.com/wp-content/uploads/2025/10/Lens-Library_Bar-Graph-4.jpg https://www.tempus.com/life-sciences/lens-library/a-pan-cancer-analysis-of-mait-cell-abundance-and-clinical-correlates/ 2026-03-26T21:12:54+00:00 https://www.tempus.com/wp-content/uploads/2025/10/Lens-Library_Violin-Plot.jpg https://www.tempus.com/life-sciences/lens-library/analyzing-specific-kras-variants-and-treatment-outcomes-in-colorectal-cancer/ 2026-03-26T21:12:54+00:00 https://www.tempus.com/wp-content/uploads/2025/10/Lens-Library_KM-Curve-3.jpg https://www.tempus.com/life-sciences/lens-library/characterizing-kras-variants-in-nsclc-with-multimodal-rwd/ 2026-03-26T21:12:55+00:00 https://www.tempus.com/wp-content/uploads/2025/10/Lens-Library_Violin-Plot-3.jpg https://www.tempus.com/life-sciences/lens-library/defining-high-risk-luad-subtypes-with-large-scale-rwd/ 2026-03-26T21:12:56+00:00 https://www.tempus.com/wp-content/uploads/2025/10/Lens-Library_Forest-Plot-2.jpg https://www.tempus.com/life-sciences/lens-library/characterizing-the-immune-microenvironment-across-nsclc-metastatic-sites/ 2026-03-26T21:12:56+00:00 https://www.tempus.com/wp-content/uploads/2025/10/Lens-Library_Bar-Graph-4.jpg https://www.tempus.com/life-sciences/lens-library/genomic-and-transcriptomic-mediators-of-adc-resistance-in-breast-cancer/ 2026-03-26T21:12:57+00:00 https://www.tempus.com/wp-content/uploads/2025/10/Lens-Library_Bar-Graph-5.jpg https://www.tempus.com/life-sciences/lens-library/genomic-profiling-of-hrd-in-soft-tissue-sarcomas/ 2026-03-26T21:12:58+00:00 https://www.tempus.com/wp-content/uploads/2025/10/Lens-Library_Co-annotation-Plot.jpg https://www.tempus.com/life-sciences/lens-library/genomic-landscape-of-kras-g12c-mutations-across-diverse-tumor-types/ 2026-03-26T21:12:58+00:00 https://www.tempus.com/wp-content/uploads/2025/10/Lens-Library_Bar-Graph-3.jpg https://www.tempus.com/life-sciences/lens-library/lag3-expression-as-a-predictive-biomarker-for-1l-ici-in-melanoma/ 2026-03-26T21:12:59+00:00 https://www.tempus.com/wp-content/uploads/2025/10/Lens-Library_KM-Curve-2.jpg https://www.tempus.com/life-sciences/lens-library/identifying-underdiagnosed-nut-carcinoma-with-rwd/ 2026-03-26T21:12:59+00:00 https://www.tempus.com/wp-content/uploads/2025/10/Lens-Library_Co-annotation-Plot.jpg https://www.tempus.com/life-sciences/lens-library/outcomes-analysis-in-her2-low-gastric-cancer-using-multimodal-rwd/ 2026-03-26T21:13:00+00:00 https://www.tempus.com/wp-content/uploads/2025/10/Lens-Library_KM-Curve-2-1.jpg https://www.tempus.com/life-sciences/lens-library/prame-expression-stratifies-treatment-response-in-nsclc-histologies/ 2026-03-26T21:13:01+00:00 https://www.tempus.com/wp-content/uploads/2025/10/Lens-Library_Forest-Plot-2.jpg https://www.tempus.com/life-sciences/lens-library/predicting-adc-efficacy-with-pdo-models-and-real-world-data/ 2026-03-26T21:13:01+00:00 https://www.tempus.com/wp-content/uploads/2025/10/Lens-Library_KM-Curve-4.jpg https://www.tempus.com/life-sciences/lens-library/predicting-osimertinib-outcomes-in-nsclc-using-liquid-biopsy-rwd/ 2026-03-26T21:13:02+00:00 https://www.tempus.com/wp-content/uploads/2025/10/Lens-Library_KM-Curve.jpg https://www.tempus.com/life-sciences/lens-library/validating-ffpe-based-genomic-profiling-in-pancreatic-cancer/ 2026-03-26T21:13:03+00:00 https://www.tempus.com/wp-content/uploads/2025/10/Lens-Library_Bar-Graph-2.jpg https://www.tempus.com/life-sciences/lens-library/validating-ec-molecular-subtypes-in-a-real-world-cohort/ 2026-03-26T21:13:03+00:00 https://www.tempus.com/wp-content/uploads/2025/10/Lens-Library_KM-Curve-3-1.jpg https://www.tempus.com/life-sciences/lens-library/integrating-ca125-and-ctdna-to-enhance-prognostic-precision-in-ovarian-cancer/ 2026-03-27T15:05:33+00:00 https://www.tempus.com/wp-content/uploads/2025/10/Lens-Library_KM-Curve-2.jpg https://www.tempus.com/life-sciences/lens-library/immune-profile-score-distribution-in-hpv16-positive-and-negative-hnscc/ 2026-03-27T15:06:30+00:00 https://www.tempus.com/wp-content/uploads/2025/10/Lens-Library_Bar-Graph.jpg https://www.tempus.com/life-sciences/lens-library/mutational-profiles-and-treatment-resistance-in-metastatic-tnbc/ 2026-03-27T15:16:21+00:00 https://www.tempus.com/wp-content/uploads/2025/10/Lens-Library_Bar-Graph-5.jpg https://www.tempus.com/life-sciences/lens-library/characterizing-cldn18-2-and-her2-expression-in-gastroesophageal-cancer/ 2026-03-27T15:28:02+00:00 https://www.tempus.com/wp-content/uploads/2025/10/Lens-Library_Forest-Plot.jpg https://www.tempus.com/life-sciences/lens-library/il33-expression-as-a-predictor-of-immunotherapy-response-in-nsclc/ 2026-03-27T15:34:31+00:00 https://www.tempus.com/wp-content/uploads/2025/10/Lens-Library_KM-Curve-3-1.jpg https://www.tempus.com/life-sciences/lens-library/stratifying-hr-her2-breast-cancer-through-er-signaling-and-g2-m-molecular-signatures/ 2026-03-27T15:40:29+00:00 https://www.tempus.com/wp-content/uploads/2025/10/Lens-Library_KM-Curve-4.jpg https://www.tempus.com/life-sciences/lens-library/high-wrn-expression-and-immunotherapy-outcomes-in-msi-h-dmmr-colorectal-cancer/ 2026-03-27T15:47:58+00:00 https://www.tempus.com/wp-content/uploads/2025/10/Lens-Library_KM-Curve-3.jpg https://www.tempus.com/life-sciences/lens-library/prognostic-impact-of-tp53-and-ppp2r1a-mutations-in-endometrial-cancer/ 2026-03-27T15:53:08+00:00 https://www.tempus.com/wp-content/uploads/2025/10/Lens-Library_KM-Curve-2-1.jpg https://www.tempus.com/life-sciences/lens-library/developing-a-gene-expression-signature-for-first-line-treatment-in-metastatic-crc/ 2026-03-27T20:35:35+00:00 https://www.tempus.com/wp-content/uploads/2025/10/Lens-Library_KM-Curve-3.jpg https://www.tempus.com/life-sciences/lens-library/impact-of-m2-like-macrophage-infiltration-on-rcc-immunotherapy-outcomes/ 2026-03-27T20:38:26+00:00 https://www.tempus.com/wp-content/uploads/2025/10/Lens-Library_KM-Curve-3-1.jpg https://www.tempus.com/publications/basecamp-1-screening-study-a-model-for-efficient-enrolment-in-precision-oncology-clinical-trials/ 2026-03-31T14:21:58+00:00 https://www.tempus.com/publications/integrin-beta-6-ib6-in-focus-contemporary-real-world-evidence-on-prevalence-in-non-small-cell-lung-cancer-nsclc/ 2026-03-31T14:47:41+00:00 https://www.tempus.com/publications/a-randomized-trial-evaluating-the-impact-of-automated-notifications-on-the-identification-and-treatment-of-patients-with-aortic-stenosis-and-mitral-regurgitation-design-of-the-alert-trial/ 2026-03-31T15:14:32+00:00 https://www.tempus.com/wp-content/uploads/2026/03/CVCT_ALERT-Abstract_centralIllustration_Final.png https://www.tempus.com/news/pr/tempus-and-medtronic-announce-alert-trial-results-showing-ai-driven-ehr-notifications-improve-treatment-for-significant-valvular-heart-disease/ 2026-04-01T14:16:04+00:00 https://www.tempus.com/resources/content/articles/improving-patient-matching-efficiency-with-an-ai-powered-platform/ 2026-04-01T14:29:20+00:00 https://www.tempus.com/wp-content/uploads/2025/10/Improving-patient-matching-efficiency-with-an-AI-powered-platform-1.jpg https://www.tempus.com/wp-content/uploads/2025/09/P-yield-article-image2.png https://www.tempus.com/resources/content/articles/oncology-innovation-how-emerging-biotechs-lead-through-rwd-and-ai/ 2026-04-01T14:30:36+00:00 https://www.tempus.com/wp-content/uploads/2025/02/Oncology-innovation_-How-emerging-biotechs-lead-through-RWD-AI.png https://www.tempus.com/wp-content/uploads/2023/04/KRAS-Expression_KRAS-Mutation-Status.png https://www.tempus.com/wp-content/uploads/2023/04/KRAS-Expression_KRAS-Mutation-Status.png https://www.tempus.com/wp-content/uploads/2023/04/KRAS-Expression_KRAS-Mutation-Status.png https://www.tempus.com/resources/content/articles/qa-a-chief-data-officers-view-on-powering-precision-medicine-with-rwd-ai/ 2026-04-01T14:31:27+00:00 https://www.tempus.com/wp-content/uploads/2025/10/QA_-A-chief-data-officers-view-on-powering-precision-medicine-with-RWD-AI.jpg https://www.tempus.com/resources/content/white-papers/bridging-the-translational-gap-the-role-of-organoids-in-oncology-rd/ 2026-04-01T14:32:34+00:00 https://www.tempus.com/wp-content/uploads/2025/06/White-Paper_bridging-the-translational-gap-the-role-of-organoids-in-oncology-rd.jpg https://www.tempus.com/publications/concurrent-tissue-and-circulating-tumor-dna-analysis-in-renal-cell-carcinoma-insights-from-a-multimodal-database/ 2026-04-07T20:56:26+00:00 https://www.tempus.com/publications/integrating-genomics-and-real-world-data-to-predict-fam-trastuzumab-deruxtecan-response-in-metastatic-breast-cancer-across-her2-subtypes/ 2026-04-07T21:02:25+00:00 https://www.tempus.com/publications/an-rna-based-survival-model-predicting-real-world-response-to-trastuzumab-deruxtecan/ 2026-04-07T21:03:14+00:00 https://www.tempus.com/publications/prospective-organoid-drug-profiling-and-clinical-response-correlation-for-patients-with-primary-or-recurrent-ovarian-carcinoma-oc-in-the-prosperity-study/ 2026-04-07T21:03:56+00:00 https://www.tempus.com/publications/chromosome-3p-mutations-drive-unique-and-non-redundant-transcriptional-programs-in-primary-ccrcc/ 2026-04-07T21:04:29+00:00 https://www.tempus.com/publications/immune-related-rna-seq-biomarker-based-clustering-reveals-heterogeneous-immunotherapy-responses-and-guides-subtype-specific-strategies-in-metastatic-nsclc-2/ 2026-04-07T21:05:08+00:00 https://www.tempus.com/publications/real-world-treatment-patterns-and-outcomes-reveal-distinct-clinical-trajectories-of-patients-with-cyclin-e1-positive-ovarian-cancer/ 2026-04-07T21:05:42+00:00 https://www.tempus.com/publications/real-world-evidence-of-kmt2c-mutation-as-a-biomarker-of-sensitivity-to-platinum-based-therapy-in-solid-cancers/ 2026-04-07T21:06:48+00:00 https://www.tempus.com/publications/high-prmt5-expression-is-associated-with-decreased-immune-infiltrate-and-worse-outcomes-to-immune-checkpoint-inhibitors-in-non-small-cell-lung-cancer/ 2026-04-07T21:07:25+00:00 https://www.tempus.com/publications/sarcomatoid-transformation-rewires-the-immune-spatial-landscape-and-checkpoint-regulation-in-chromophobe-renal-cell-carcinoma-2/ 2026-04-07T21:07:53+00:00 https://www.tempus.com/publications/prevalence-and-association-of-clonal-hematopoiesis-with-cardiovascular-health-in-patients-of-the-avera-sequencing-and-analytics-protocol-asap-study/ 2026-04-07T21:08:22+00:00 https://www.tempus.com/publications/braf-copy-number-alterations-and-ultralow-braf-mrna-expression-are-prognostic-for-poor-overall-survival-in-prostate-cancer/ 2026-04-07T21:08:55+00:00 https://www.tempus.com/publications/reasoning-guided-retrieval-improves-oncology-trial-eligibility-matching-from-clinical-notes/ 2026-04-07T21:09:27+00:00 https://www.tempus.com/publications/profiling-membrane-antigen-expression-of-select-antibody-drug-conjugate-adc-targets-in-egfr-altered-non-small-cell-lung-cancer-treated-with-osimertinib/ 2026-04-07T21:10:17+00:00 https://www.tempus.com/publications/comparison-of-tissue-and-liquid-biopsy-cgp-in-advanced-solid-tumors-insights-from-a-community-cancer-center/ 2026-04-07T21:10:47+00:00 https://www.tempus.com/publications/egfr-s442-mutation-confers-cetuximab-resistance-that-can-be-overcome-by-erbb2-blockade-by-trastuzumab-deruxtecan/ 2026-04-07T21:11:19+00:00 https://www.tempus.com/publications/evaluating-prognostic-biomarkers-in-advanced-epithelial-ovarian-carcinoma-using-machine-learning-on-real-world-data/ 2026-04-07T21:11:48+00:00 https://www.tempus.com/publications/an-agentic-ai-workflow-for-automated-high-fidelity-curation-of-cancer-diagnosis-and-staging-from-unstructured-patient-records/ 2026-04-07T21:12:17+00:00 https://www.tempus.com/publications/msi-colon-adenocarcinoma-transcriptomic-subtypes-are-biomarkers-of-response-to-immunotherapy/ 2026-04-07T21:12:47+00:00 https://www.tempus.com/publications/elevating-bulk-sequencing-with-high-resolution-spatial-transcriptomics-a-paired-data-analysis-of-clinically-relevant-spatial-niches-in-crc-and-nsclc/ 2026-04-07T21:13:56+00:00 https://www.tempus.com/publications/genomic-characterization-of-lung-cancer-errfi1-and-nkx2-1-mutations-and-clu-expression/ 2026-04-07T21:14:25+00:00 https://www.tempus.com/publications/pan-cancer-assessment-of-an-rna-based-signature-of-hrd/ 2026-04-07T21:14:52+00:00 https://www.tempus.com/publications/identifying-biomarkers-of-response-in-braf-p-v600e-mutant-colorectal-cancers-mcrc/ 2026-04-07T21:15:20+00:00 https://www.tempus.com/publications/integrated-clinicopathologic-genomic-and-transcriptomic-characterization-of-gastric-cancer-by-race-ethnicity-in-a-national-multi-institutional-cohort/ 2026-04-07T21:15:48+00:00 https://www.tempus.com/publications/molecular-and-immune-landscape-of-her2-amplified-colorectal-cancer/ 2026-04-07T21:16:18+00:00 https://www.tempus.com/publications/detection-of-rare-oncogenic-fusions-through-concurrent-dna-and-rna-next-generation-sequencing-in-a-pan-cancer-clinical-setting/ 2026-04-07T21:18:30+00:00 https://www.tempus.com/publications/machine-learning-predicts-retinoblastoma-rb-function-in-real-world-small-cell-lung-cancer-patients/ 2026-04-07T21:19:01+00:00 https://www.tempus.com/publications/a-patient-derived-fragmented-tumor-assay-for-detailed-evaluation-of-drug-response-in-the-tumor-microenvironment-tme-using-scrnaseq/ 2026-04-07T21:19:34+00:00 https://www.tempus.com/publications/validation-of-her2-trop2-and-nectin4-ihc-prediction-algorithms-for-the-adc-match-trial/ 2026-04-07T21:20:03+00:00 https://www.tempus.com/publications/lauren-subtype-classification-in-gastric-cancer-using-deep-learning-on-real-world-he-images/ 2026-04-07T21:20:32+00:00 https://www.tempus.com/publications/large-scale-analysis-reveals-distinct-molecular-subtypes-in-real-world-gastric-cancer-data/ 2026-04-07T21:21:27+00:00 https://www.tempus.com/publications/multimodal-ai-for-patient-subtype-discovery-in-lusc-using-real-world-data/ 2026-04-07T21:22:03+00:00 https://www.tempus.com/publications/beyond-hla-loh-alternative-modes-of-hla-loss-are-common-and-vary-by-cancer-type/ 2026-04-07T21:22:34+00:00 https://www.tempus.com/publications/immune-related-rna-seq-biomarker-based-clustering-reveals-heterogeneous-immunotherapy-responses-and-guides-subtype-specific-strategies-in-metastatic-nsclc/ 2026-04-07T21:23:08+00:00 https://www.tempus.com/publications/co-occurrence-of-gene-fusions-and-microsatellite-instability-msi-defines-a-clinically-distinct-subtype-of-colorectal-cancer/ 2026-04-07T21:23:39+00:00 https://www.tempus.com/publications/automated-alerts-to-improve-timely-evaluation-and-treatment-of-valvular-heart-disease-the-alert-trial/ 2026-04-08T18:52:10+00:00 https://www.tempus.com/publications/tumor-specific-lncrna-igf1r-as1-trans-regulates-chromatin-interactions-associated-with-oncogenic-myc-signaling/ 2026-04-08T19:00:17+00:00 https://www.tempus.com/publications/outcomes-with-avelumab-maintenance-treatment-for-advanced-urothelial-cancer-in-a-us-patient-cohort/ 2026-04-08T19:07:35+00:00 https://www.tempus.com/publications/landscape-of-somatic-genetic-alterations-and-pam50-intrinsic-subtypes-in-breast-cancer-associated-with-germline-pathogenic-variants-in-dna-repair-genes/ 2026-04-08T19:13:43+00:00 https://www.tempus.com/news/pr/tempus-to-present-at-the-25th-annual-needham-virtual-healthcare-conference/ 2026-04-08T20:02:04+00:00 https://www.tempus.com/news/pr/tempus-announces-strategic-collaboration-with-gilead-to-advance-oncology-rd-through-rwe/ 2026-04-09T13:47:13+00:00 https://www.tempus.com/resources/content/articles/expanding-the-boundaries-of-precision-medicine-and-research-with-tempus-one/ 2026-04-09T15:44:44+00:00 https://www.tempus.com/wp-content/uploads/2025/01/One-@-JPM-thumbnail-1.jpg https://www.tempus.com/news/pr/tempus-launches-automated-active-follow-up-service-to-support-guideline-concordant-care/ 2026-04-13T12:30:06+00:00 https://www.tempus.com/resources/content/articles/spatial-transcriptomics-vendor/ 2026-04-13T12:47:39+00:00 https://www.tempus.com/resources/content/articles/vendor-offering-dna-and-rna-sequencing-precision-oncology/ 2026-04-13T13:03:54+00:00 https://www.tempus.com/publications/impact-of-tumor-mutational-burden-on-clinical-outcomes-in-muscle-invasive-bladder-cancer-patients-treated-with-neoadjuvant-chemotherapy/ 2026-04-13T15:50:29+00:00 https://www.tempus.com/publications/validation-of-he-based-laboratory-development-test-predicting-molecular-alterations-in-non-small-cell-lung-cancer/ 2026-04-13T16:22:56+00:00 https://www.tempus.com/wp-content/uploads/2026/03/1.jpg https://www.tempus.com/wp-content/uploads/2026/03/2.jpg https://www.tempus.com/publications/ai-based-prediction-of-microsatellite-instability-in-solid-tumors-a-cost-effective-screening-strategy-for-cancer-immunotherapy/ 2026-04-13T16:24:01+00:00 https://www.tempus.com/publications/laboratory-development-test-validation-of-an-he-based-deep-learning-histogenomic-model-to-predict-biomarkers-in-endometrial-cancer/ 2026-04-13T16:32:39+00:00 https://www.tempus.com/wp-content/uploads/2026/04/Screenshot-2026-04-13-at-11.29.15-AM.png https://www.tempus.com/wp-content/uploads/2026/04/fx1_lrg.jpg https://www.tempus.com/events/sgo-2026-annual-meeting-on-womens-cancer/ 2026-04-14T00:20:44+00:00 https://www.tempus.com/events/acc-2026/ 2026-04-14T00:21:03+00:00 https://www.tempus.com/events/uscap-2026/ 2026-04-14T00:21:17+00:00 https://www.tempus.com/events/aacr-annual-meeting-2025/ 2026-04-14T00:21:29+00:00 https://www.tempus.com/events/world-cb-cdx-europe-2026/ 2026-04-14T00:21:43+00:00 https://www.tempus.com/events/uscap-2023/ 2026-04-14T00:21:57+00:00 https://www.tempus.com/events/ras-drug-development-2023/ 2026-04-14T00:22:09+00:00 https://www.tempus.com/events/dpharm-2023/ 2026-04-14T00:22:22+00:00 https://www.tempus.com/events/tumormodels2023/ 2026-04-14T00:22:35+00:00 https://www.tempus.com/events/next-generation-dx2023/ 2026-04-14T00:23:39+00:00 https://www.tempus.com/events/13th-annual-world-clinical-biomarkers-cdx-summit/ 2026-04-14T00:23:54+00:00 https://www.tempus.com/events/oct-wc-2026/ 2026-04-14T00:24:55+00:00 https://www.tempus.com/events/tumor-models-san-francisco-2026/ 2026-04-14T00:25:07+00:00 https://www.tempus.com/events/asco-gi-2026/ 2026-04-14T00:25:19+00:00 https://www.tempus.com/events/sitc-2025/ 2026-04-14T00:25:32+00:00 https://www.tempus.com/events/sabcs-2025/ 2026-04-14T00:25:45+00:00 https://www.tempus.com/events/ash-2025/ 2026-04-14T00:25:59+00:00 https://www.tempus.com/events/ispor-2026/ 2026-04-14T00:39:04+00:00 https://www.tempus.com/events/acrp-2026-annual-conference/ 2026-04-14T00:39:07+00:00 https://www.tempus.com/events/aacr-annual-meeting-2026/ 2026-04-14T00:39:11+00:00 https://www.tempus.com/publications/calibrating-observational-health-record-data-against-a-randomized-trial-2/ 2026-04-14T17:35:03+00:00 https://www.tempus.com/publications/outcomes-for-patients-with-spop-mutated-castration-resistant-prostate-cancer-crpc-treated-with-an-androgen-receptor-pathway-inhibitor-arpi-2/ 2026-04-14T17:46:43+00:00 https://www.tempus.com/publications/generic-protocols-for-analytical-validation-of-tumor-informed-circulating-tumor-dna-assays-for-molecular-residual-disease-the-blood-profiling-atlas-in-cancers-molecular-residual-disease-analytical/ 2026-04-14T17:50:35+00:00 https://www.tempus.com/publications/assessment-of-the-adequacy-of-the-fast-healthcare-interoperability-resources-fhir-genomics-standard-for-the-representation-of-somatic-testing-reports/ 2026-04-14T17:54:21+00:00 https://www.tempus.com/publications/lexicon-for-clonal-hematopoiesis-in-liquid-biopsy/ 2026-04-14T17:57:16+00:00 https://www.tempus.com/publications/molecular-characteristics-and-clinical-outcomes-of-gastroesophageal-cancer-diagnosed-at-age/ 2026-04-14T18:42:19+00:00 https://www.tempus.com/resources/content/articles/tempus-target-validation-support-vendor/ 2026-04-15T12:57:06+00:00 https://www.tempus.com/resources/content/articles/advanced-cardiac-ai-solutions/ 2026-04-15T13:57:30+00:00 https://www.tempus.com/resources/content/articles/advanced-ways-to-identify-cardiovascular-disease/ 2026-04-15T13:57:36+00:00 https://www.tempus.com/resources/content/articles/companies-offering-mrd-testing/ 2026-04-15T13:57:44+00:00 https://www.tempus.com/resources/content/articles/identify-patient-treatment-gaps-ai-journey-analytics/ 2026-04-15T13:57:52+00:00 https://www.tempus.com/resources/content/articles/ai-clinical-note-taker-psychiatry/ 2026-04-15T13:57:59+00:00 https://www.tempus.com/news/pr/tempus-and-predicta-biosciences-announce-collaboration-to-expand-life-sciences-access-to-ultrasensitive-whole-genome-sequencing-assay-for-hematologic-malignancies-and-mrd-monitoring/ 2026-04-15T14:02:37+00:00 https://www.tempus.com/resources/content/articles/the-landmark-journey-of-paige-prostate-ivdr-approval-and-building-on-a-legacy-of-regulatory-excellence-as-the-first-fda-authorized-ai/ 2026-04-15T15:46:10+00:00 https://www.tempus.com/wp-content/uploads/2026/04/the-landmark-journey-of-paige-prostate-ivdr-approval-and-buildling-on-a-legacy-of-regulatory-excellence-as-the-first-fda-authorized-ai.jpg https://www.tempus.com/wp-content/uploads/2026/04/landmark-journey-of-paige-prostate-graph-3.png https://www.tempus.com/wp-content/uploads/2026/04/paige-prostate-fda-ivdr-slide1.png https://www.tempus.com/wp-content/uploads/2026/04/paige-prostate-fda-ivdr-slide2.png https://www.tempus.com/resources/content/case-studies/utilizing-real-world-external-controls-for-regulatory-decision-making/ 2026-04-16T15:15:07+00:00 https://www.tempus.com/resources/content/articles/the-multimodal-imperative-leveraging-integrated-data-streams-to-accelerate-oncology-research-and-drug-development/ 2026-04-16T16:27:51+00:00 https://www.tempus.com/wp-content/uploads/2026/04/The-multimodal-imperative_-Leveraging-integrated-data-streams-to-accelerate-oncology-research-and-drug-development.jpg https://www.tempus.com/resources/content/articles/vendors-support-biomarker-discovery/ 2026-04-16T18:59:18+00:00 https://www.tempus.com/resources/content/articles/vendors-companies-offering-testing-colorectal-cancer/ 2026-04-16T20:50:54+00:00 https://www.tempus.com/news/pr/tempus-to-report-first-quarter-2026-financial-results-on-may-5/ 2026-04-21T12:30:09+00:00 https://www.tempus.com/resources/content/case-studies/tempus-next-pathways-unlocked-critical-insights-into-the-ansclc-patient-journey-with-bristol-myers-squibb-bms/ 2026-04-21T18:08:30+00:00 https://www.tempus.com/wp-content/uploads/2026/04/BMS-Case-Study_thumbnail.png https://www.tempus.com/events/asco-2026/ 2026-04-21T20:13:05+00:00 https://www.tempus.com/resources/content/articles/ai-powered-clinical-research-an-integrated-solution-for-pre-screening/ 2026-04-22T15:43:08+00:00 https://www.tempus.com/wp-content/uploads/2026/04/AI-powered-clinical-research-An-integrated-solution-for-pre-screening.jpg https://www.tempus.com/news/pr/tempus-and-usc-announce-strategic-collaboration-to-accelerate-ai-driven-precision-medicine/ 2026-04-23T12:30:20+00:00 https://www.tempus.com/news/pr/tempus-announces-31-abstracts-for-presentation-at-the-american-association-for-cancer-research-annual-meeting-2026/ 2026-04-23T19:40:19+00:00 https://www.tempus.com/publications/validation-of-a-composite-mortality-end-point-in-a-large-clinicogenomic-real-world-database-of-patients-with-advanced-cancer/ 2026-04-23T19:56:14+00:00 https://www.tempus.com/resources/content/webinars/unlocking-foundation-models-our-experience-from-proof-of-concept-to-deployment-at-scale/ 2026-04-23T21:51:24+00:00 https://www.tempus.com/wp-content/uploads/2026/04/Webinar_our-approach-to-foundation-models.png https://www.tempus.com/resources/content/articles/computational-power-limits-oncology-innovation-heres-why/ 2026-04-24T17:10:04+00:00 https://www.tempus.com/wp-content/uploads/2026/04/computational-power-of-tempus.jpg